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SUMMARY  
 T cells of the immune system recognize small antigen peptide fragments loaded 
onto Major Histocompatibility Complex (MHC) molecules through their T Cell Receptor 
(TCR). The recognition of antigenic pMHC by the TCR is an extremely sensitive and 
specific process, discriminating as few as a single antigenic pMHC from the self majority 
while remaining tolerant to uninfected cells. This unique sensitivity and specificity have 
been intensely studied, but much is still unknown regarding mechanisms surrounding the 
antigen recognition process.  
In the following studies, a Horizontal Atomic Force Microscope (HAFM) was 
developed to assist in parsing this unique behavior. Utilizing this system, periods of 
upregulated adhesion, called TCR ligand memory, were investigated between 1E6 TCR 
and a panel of pMHC of varying potency. The strength of these periods of upregulated 
adhesion, indicative of an upregulated sensitivity to antigen, inversely correlated with 
antigen potency. Inhibition of proximal signaling molecule Lck decreased the triggering of 
these periods, but did not significantly affect their duration. Interestingly, membrane 
cholesterol oxidation by cholesterol oxidase eliminated TCR ligand memory all together. 
Treatment with cholesterol sulfate, a naturally occurring analog of cholesterol, depleted 
TCR ligand memory in a dose-dependent fashion. This behavior was simulated to extract 
estimates of kinetic parameters and showed that TCRs upregulated their kinetics several 
magnitudes very quickly upon initial antigen recognition. This mechanism is a way to 
increase antigenic sensitivity and increase antigen rebinding to further cell activation. 
 xiv 
Additionally, OT-1 double positive thymocytes were probed by pMHC using a 
Biomembrane Force Probe (BFP) with different ligands under the presence of CD8, a 
coreceptor which also binds MHC independently of TCR. Negatively selecting ligands 
resulted in catch-bonds, and positively selecting ligands resulted in slip bonds. This process 
relied on the kinase activity of Lck. Simulation-based analysis on these data sets indicated 
that this mechanism was not the result of passive processes. Force induced formation of 
long-lived bonds, indicating that mechanical forces are priming formation of a larger 
complex which enhances lifetime. These bonds dominate the average lifetime and result in 
catch-bond behavior. Simulations of the BFP assay suggest that mechanotransduction by 
the TCR resulted in active heterodimerization of CD8 and TCR via interactions between 
intracellular tails of CD3(TCR) and Lck(CD8). This mechanism results in additional 
upregulation of binding kinetics for increasing antigen capture and rebinding to promote 






CHAPTER 1. INTRODUCTION 
The human body is remarkably complex machine. With the discovery of the first cells 
by Robert Hook in the 17th century [1] and the further formulation of cell theory over a 
century later [2], we know that this complex machine is composed of trillions of cells 
seamlessly working together to perform tasks necessary for us to survive. If we add to it 
the complexity of the cellular machinery and all its levels of regulation, the problem of 
understanding the human body in all its intricacies is simply mind-boggling, possibly 
outside the capacity for human knowledge. From this scope, the entire premise of survival 
and disease becomes overwhelming. 
Ultimately, the goal of understanding the human body is to give context to the 
diseases which disrupt it, leading to better and more informed treatments. Despite the 
pathology of disease being seen largely at a systems level, diseases in the human body, 
spanning from autoimmune disorders to the common cold, originate or interact at the 
cellular level [3]. This cellular activity eventually manifests itself in affecting system level 
functions. Therefore, if we center our search for understanding diseases by examining the 
fundamental effector units – the cells themselves – then we can begin to understand specific 
aspects of these diseases. This approach narrows the range of potential treatments and 
streamlines the identification of clinical intervention points.  
As alluded to earlier, the cell itself is a remarkably complex machine. If the cell is a 
machine, the proteins are the principle components which perform its function. Therefore 
to understand the cell, we must begin by understanding the proteins themselves. Several 
layers of difficulty convolute the investigation of proteins, but it primarily originates from 
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the inability to adequately visualize their processes. Proteins are smaller than the diffraction 
limit (approximately 10 nm). Therefore, the field uses a variety of techniques to circumvent 
this limitation. Entire subfields are dedicated to one of a few of these assays. Some 
visualize protein movement and organization by tagging proteins with fluorescent dyes or 
other markers through specialized microscopy techniques [4]. Others visualize their 
modifications in bulk assays such as Western blot techniques [5] and flow cytometry [6] 
after probing interactions by modifying proteins or providing different stimuli. Entire fields 
are dedicated to simply visualizing a single protein’s structure or binding properties [7]. 
All this data is later disseminated by review papers and text books to draw conclusions 
about the inner workings of the cell.  
Despite the vast amount of available data by molecular biology approaches, 
predictions were, and still frequently are, generalized as unquantified influences, such as 
upregulation of activity, on other molecular interactions. These influences are outlined as 
static connection diagrams which describe the influences of multiple molecular pathways. 
From a homeostatic perspective, this helps to better understand what gives rise to many 
cellular behaviors. However, if a molecule can be activated, inhibited, expressed or 
degraded by a series of other controlled reactions, all under the influences of external 
factors such as molecular expression or micro-environmental cues, homeostatic influences 
cannot suffice to understand the complexity of even a single molecule’s influence on the 
system as a whole.  
Computational systems biology approaches attempt to unify the vast amount of 
information available from molecular biology to converge on the true interaction network. 
This, in turn, will lead to a better understanding of the cell itself and further progress the 
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goal of better and more informed disease treatments. There are considered two arms of the 
computational systems biology [8], data-mining and simulation-based analysis. Moving 
forward, the focus will be on simulation-based analysis.   
Much of the focus of simulation-based analyses is placed on kinetics rates and 
affinities of receptor-ligand binding. The Zhu lab has developed several techniques to assist 
in measuring the kinetics of receptor-ligand interactions spanning across two membranes 
– called two-dimensional, or 2D, kinetics – which are critical in governing communication 
between to cells in contact. Because membranes of cells act to isolate the intracellular 
machinery which governs cell responses, intercellular communication across membranes 
is a cornerstone of cell-cell communication. This communication stems from several 
factors, but a significant influence is the result of receptor-ligand interactions linking two 
opposing membranes, allowing signals to be directly transmitted from cell to cell. How 
quickly receptors bind and dissociate, governed by the on- and off-rates of the interaction 
respectively, are critical parameters in shaping the response.  
However, in many experimental 2D kinetics assays, the receptor-ligand interaction is 
in the cellular context, allowing modifications and signaling to occur; the cell is often 
thought of as being “tickled” with its ligand by the experimenter. It is natural to assume 
that this “tickling” may induce changes to the cell over time as the result of prior binding 
events, yet the result is often summarized as a single kinetic rate or affinity and correlated 
with complex behaviors which are often significantly downstream of binding. In essence, 
although the presented information is more easily digested by the reader, some information 
in the series of binding events is lost by the use of summary parameters, similar to the loss 
of information in molecular biology approaches discussed previously. In this manuscript, 
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simulation-based analyses will be used in tandem with experimental assays to draw more 
information from these complex 2D binding assays. 
 The focus of this manuscript will be on a primary molecular interaction of the 
adaptive immune response – that of the T Cell Receptor (TCR) binding to its ligand, a 
peptide fragment loaded onto Major Histocompatibility Complex (pMHC). From its 
discovery in 1982-83 [9-11], a significant amount of study has been aimed toward 
understanding its function and regulation. However, despite the large body of research into 
its role in adaptive immunity, the biophysical aspects of discrimination of foreign peptides 
are still incompletely understood. The majority of the difficulty arises from the fact that 
antigenic pMHC, those coming from foreign pathogens, are typically low in number 
compared to self pMHC, those which are naturally displayed on the surface of all cells in 
the body [12]. Therefore, the TCR must have enough power to detect low amounts of 
antigen on infected or diseased cells, while also not eliciting a response to healthy cells 
expressing only self pMHC.  
Much of the focus of antigen recognition and discrimination has been placed on the 
kinetics of the interaction, making it an excellent study for the 2D kinetic assay tools in the 
Zhu lab and simulation-based analyses. In this study, a new tool was developed in the Zhu 
lab, Horizontal Atomic Force Microscopy (HAFM), to assist in performing some of the 
assays required to investigate TCR kinetic regulation. This tool was used to investigate 
transiently upregulated TCR-pMHC binding periods which are thought to enhance the 
discriminatory capabilities of the TCR. Lastly, a mechanism controlling the mechanical 
activation of TCR and binding of coreceptor CD8 in thymocytes to enhance antigen 
discrimination was investigated through simulation-based analyses. 
 5 
CHAPTER 2. BACKGROUND 
2.1 T cells in immunity 
In brief, there are two main components to our immune systems - innate and adaptive 
immunity – composed of many different cell types originating from the bone marrow [13]. 
Innate immunity provides the first line of defense to invading pathogens, and relies heavily 
on recognition of generic patterns. T lymphocytes, or T cells, are a major component of the 
body’s adaptive immune system, the second line of defense, which depends on innate 
immune functions to develop a response. After pathogen clearance, adaptive immunity has 
the ability to recognize the same pathogen upon future infection and expedite its clearance.  
2.1.1 Thymic development 
T cells begin as pluripotent hematopoietic stems cells in the bone marrow, and 
transition to the thymus for training. Here, they are referred to as thymocytes, and are not 
yet involved in immune functions. In the thymus, thymocytes undergo development of a 
functional TCR, positive selection by appropriate self pMHC binding, and determination 
of lineage fate [14-16]. In short, the thymus positively selects T cells to respond to self 
pMHC, a response called tonic signalling which is required for T cell survival [17], while 
eliminating cells which respond too strongly in a process called negative selection [18]. 
This results in a pool of cells which do not respond adversely to healthy cells, but which 
has the possibility of recognizing non-self, or antigenic peptides; the reasoning for such a 
mechanism will become more clear in Section 2.2.3. After thymocytes undergo the 
selection process, naïve T cells leave the thymus and enter circulation. 
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2.1.2 T cell activation 
The series of events required for T cell activation after infection is well-defined. 
First, antigen from the infected site is delivery through innate recognition or other passive 
processes through the lymphatic system to a draining lymph node and presented on Antigen 
Presenting Cells (APCs). After antigen delivery to the lymph nodes, naïve T cells have the 
ability to recognize pathogenic pMHC in the lymph nodes through their specific TCR and 
become activated by forming a well-characterized, complex structure between T cell and 
APC known as the immunological synapse [19-22]. Subsequently, the cells undergo clonal 
expansion. This expansion leads to a large pool of effector cells with the same TCR 
recognizing the same pathogenic pMHC. These cells either return to circulation and the 
site of infection to identify and kill other infected cells presenting the same pathogenic 
MHC or release cytokines which help prime other immune cells to boost other proximal or 
humoral immune responses [13, 23]. Once the pathogen has been removed from the body 
by this response, a small number of the remaining effector cells transition into a memory 
state to act upon future infection by the same or similar pathogens [24]. 
It is important to note that these are only the classical responses induced by antigen 
recognition. There are several other subtypes of T cells that behave differently or have 
other roles (discussed further in section 2.1.3.2). Additionally, the picture is very complex, 
involving many other molecular and biochemical players which act to modulate the 
response. However, the basic progression of the activation cycle is similar – antigen uptake, 
presentation in the lymph nodes, TCR recognition, expansion, recirculation, further TCR 
recognition in tissues, and lastly, effector response. 
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2.1.3 T cell subsets 
As the field of immunology develops, many different subsets of T cells are defined, 
all with differential behaviours and responses. We will briefly go over some of them here. 
However, as the literature grows, these subsets are more guidelines than fixed points. Cells 
have remarkable plasticity; switching between subsets has been known to occur and 
concrete classifications of cell behaviours is being constantly revised [25].  
2.1.3.1 Classical T cell subsets: CD4+ vs. CD8+ T cells 
The coreceptors CD8 and CD4 bind to MHC class I and II, respectively, 
independent of the TCR binding site to enhance the activation upon antigen recognition 
[26]. In addition to their role in antigen recognition (discussed in Section 2.3.5), the 
presence of either coreceptor is exclusive and indicates a specific lineage fate [13]. CD8+ 
positive cells are the effective targeted killers of the immune system. Upon pathogenic 
pMHC recognition in the lymph nodes, differentiated cytotoxic effector CD8+ T cells are 
the foot soldiers of the immune system that seek out and kill other infected cells throughout 
the body to prevent the spread of disease. Naturally, there are subsets of these (discussed 
in [27]). If CD8+ cells are the foot soldiers, CD4+ cells are their diverse set of commanders, 
playing multiple roles to orchestrate the defense through the release of different cytokines. 
These include TH1, TH2, TH9, TH17, TH22, Treg, and TFH [28] although there are subsets of 
even these cell subtypes [29-32]. These cells display wide variety of roles range from 
upregulating innate responses and antibody production to shutting down even these same 
roles.  
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Both CD4+ and CD8+ positive cells however require initial antigen recognition 
through their TCR, albeit by different means. CD8+ positive cells recognize only class I 
pMHC, which is expressed on all cell types throughout the body. They must be able to 
eliminate any cell that is infected while not allowing the pathogen to spread by tightly 
controlling their disposal by apoptosis. However, CD4+ cells, which have TCRs only 
recognizing only class II pMHC, only respond to professional APCs. The different MHC 
classes allows a delineation of effector functions, stemming from how the peptides are 
processed. More will be discussed about this in Section 2.2.3.  
2.1.3.2 Non-classical subsets 
Although not necessarily important to this study, it is important to note that there are 
several other subsets of T cells that do not necessarily recognize pMHC; their responses to 
antigen through different receptors may be similar and the mechanisms by which they are 
triggered could be related. Natural Killer T cells recognize glycolipids presented on another 
molecule, CD1d [33, 34]. Mucosal Associated Invariant T cells respond to MR1 bound 
vitamin B metabolites, although their function is more innate and less adaptive [33, 34]. 
Up to this point, all mention of TCR has been of the majority  heterodimer, although 
there is another subset of T cells expressing a different form -  - aptly named  T cells, 
reviewed in [35]. From this point forward, all mention of TCR will be . 
2.2 T cell antigen recognition through the TCR 
The TCR is the central node of T cell activation and the primary molecule of interest 
for this study. Since its discovery nearly in the early 80s [9-11], a significant amount of 
research has uncovered several aspects key to how it recognizes antigen and signals 
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activation of the cell. Some of that will be reviewed in this section. There are several key 
aspects to understanding any receptor-ligand interaction – the structure and signaling 
capacities. In the case of TCR-pMHC interactions, it is also critical to understand the 
origins of the peptides themselves. These concepts will be discussed in this section. 
2.2.1 TCR-pMHC structure 
The TCR is a membrane-bound heterodimer of immunoglobulin (Ig)-like chains 
encoded by several different gene regions – variable, diversity, joining, and constant – 
which are organized during thymic development [36]. Due to somatic rearrangement of 
these regions, there are a theoretically estimated 1015 to 1020 unique combinations of TCRs 
[37], although practical limitations constrain the true diversity to around 107-108 [38]. Each 
T cell will express only one of these unique combinations. Considering that each TCR and 
can cross-react with possibly several different pMHCs, the potential peptide sequences 
which can be recognized by T cells is enormous.  
On the pMHC side, the structure is slightly simpler, but no less diverse due to MHC 
class restriction and the presence of two components – both the peptide and the MHC itself. 
Class I and II MHC have slightly different structures. MHC Class I is composed of three 
globular domains, 1-3, stabilized by Beta-2 Microglobulin (Figure 1A). The short 
peptide sequence, approximately 8-12 amino acids in length, sits in a groove between the 
1 and 2 domains. MHC Class II is composed of two chains consisting of two domains 
each - . The longer peptide sequence (>11 amino acids) sits in the groove between the 
1 and 1 domains (Figure 1B). 
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Figure 1. Cartoon depiction of MHC Class structure 
  [39] 
The majority of the TCR diversity is encoded by the variable region most distal to 
the cell membrane. Due to the massive diversity of the TCR pool, many different structures 
must be resolved to make generalizations about the origins of ligand recognition. Since the 
first TCR-pMHC structure was first resolved by x-ray crystallography in 1996 [40], over 
100 different structures have been solved. Six TCR loops, CDR1-3 for each chain, govern 
the interaction with both the MHC and peptide [41, 42]. TCRs tend to overlap the peptide 
at a well-conserved binding angle (see [43] for binding angles), with the CDR loops making 
contacts on the peptide. However, some CDR loops also contact the MHC itself [41, 43], 
indicating that the TCR recognizes aspects of both the MHC and peptide.  
2.2.2 TCR signalling and regulation 
Due to the cell membrane barrier isolating cellular machinery, information from 
outside the cell must be transferred across the membrane in the form of receptor-ligand 
binding. Typically, information from binding produces signalling in the form of a 
biochemical signal inside the cell. The TCR only carries a short intracellular domain and 
(A) MHC Class I structure. Peptide sits in groove between 1 and 2 domains. (B) MHC 
Class II structure. Peptide resides between 1 and 1 domains. Figure adapted from 
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does not contain any intracellular signalling domains of its own. Therefore, this 
information transfer relies wholly on another molecular interaction, the interaction between 
TCR and CD3 subunits that organize themselves around the TCR. Stoichiometric assays 
have determined there are three CD3 dimers - , , and  – that non-covalently associate 
with the TCR, each containing one or more Immunoreceptor Tyrosine-based Activation 
Motifs (ITAMs) required for biochemical signalling [41, 44]. These ITAMs become 
phosphorylated upon activation of the T cell [45]. The initial phosphorylation of ITAMs 
and accumulation of signal, referred to as TCR triggering or TCR activation, is a central 
event in the activation of T cells. As few as a single antigenic pMHC interaction can result 
in cell activation [46-48]. Therefore, understanding the regulation of this information 
transfer is critical in understanding the immune response. 
The sequence of events in TCR triggering is well described in the literature. Briefly, 
CD3 ITAMs in a resting T cell are thought to be buried in the membrane where they are 
not accessible for phosphorylation due to the strong negative charge of the inner leaflet and 
positively charged sequences on the CD3 tails [49, 50]. Upon pMHC engagement, the 
ITAMs are exposed for phosphorylation by Src family tyrosine kinase Lck [51]. After an 
ITAM has been doubly phosphorylated, Syk family kinase Zeta-chain-Associated 70 kDa 
tyrosine Phosphoprotein (ZAP-70) can bind through its tandem SH2 domains, releasing an 
inhibitory state and enabling it to become phosphorylated (by Lck or trans-phosphorylated 
by other ZAP-70), stabilizing an active conformation. ZAP-70 then begins a chain of events 
by phosphorylating many different molecules, primarily scaffolding or signalling proteins 
such as Linker for the Activation T cells (LAT) and SH2-domain-containing Leukocyte 
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Protein of 76 kDa (SLP-76) [52, 53]. These molecules continue a cascade of activation, 
resulting in full T cell activation. 
TCR activation is a very dynamic process involving multiple levels of regulation; 
this begins at the TCR itself. In a resting T cell, the TCR resides in nanodomains and 
clustered by lipid rafts on resting T cells [54, 55], which concatenate upon antigen 
recognition into large microclusters symptomatic of immunological synapse formation. 
Receptor pre-clustering controls receptor sensitivity [56] and has been shown to be relevant 
with TCR [54, 57]. In addition to the clustering effects of lipid rafts, cholesterol binds the 
TCR, resulting in downregulation of signalling [55, 58-60]. This indicates several levels of 
control at the TCR level. 
Intracellular regulation of signalling occurs at many points. Lck has several 
different phosphorylated forms, each with different kinetics [61], to regulate initial ITAM 
phosphorylation rates. ZAP-70 and the ITAMs also have their own levels of regulation 
discussed previously. In addition, phosphatases and other kinases, such as SHP isoforms 
and Csk, control the phosphorylation patterns of these molecules, typically themselves 
under the control of co-stimulatory and co-inhibitory receptors [62]. In summary, the TCR 
signalling complex is chaotic, but tightly controlled, through a combination of factors [63].  
2.2.3 Antigenic and self pMHC origins 
Antigens are any substance that induces your body to produce a specific antibody 
for it; however, it is more broadly used to define any toxin or foreign substance that induces 
an immune response. Traditionally, MHC class I and II molecules present peptides to be 
recognized by CD8+ and CD4+ T cells, respectively. The origins of the peptide fragment 
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depend on the source of the protein – intracellular peptides for MHCI and exogenous 
peptides for MHCII. However, the presented peptides derive from proteolysis by the 
proteasome [64] and is occurring in healthy or infected cells. Importantly, this process is 
does not discriminate between proteins of different origins; it simply degrades those which 
have been targeted for degradation.  
Therefore, if a virus begins hijacking the cell, pieces of the proteins it expresses 
which are not expressed by a healthy cell will become expressed alongside those of the 
natural protein fragments. The result is pMHC are both antigenic and self. However, due 
to the dominance of self-proteins in the cell, self-peptides dominate the expression [12, 
65]. This is a critical point. TCRs must be able to differentiate small differences in the 
peptide sequence to determine if a cell is infected while maintaining tolerance (not 
triggering) to a cell expressing only self-peptides. The result of faulty recognition can have 
dire consequences on the body in the form of autoimmune diseases. This discrimination is 
a crucial factor under significant investigation. However, to date, the discriminatory 
capabilities of TCR antigen recognition have not been reconciled with the high sensitivity 
of antigen detection [51]. Previous efforts to do so will be summarized in Section 2.3. 
2.3 Models of TCR antigen recognition and self-peptide discrimination 
Mathematical models and simulation-based analysis have been used to elucidate 
many different mechanisms in receptor activation [8]. Beginning soon after the discovery 
of the TCR, its mechanism has been under investigation through computational simulations 
and mathematical modelling. This will be discussed in this section. 
2.3.1 Receptor occupancy model 
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One of the earliest models of TCR signalling, named receptor occupancy or 
affinity-based model, assumes that the response of the T cell is governed by the fraction of 
TCRs bound to pMHC. This model gained popularity in many circles because of the TCR’s 
similarity to many other receptors and basic tenants of pharmacology with its origins the 
early 20th century [66]. Because antigenic MHCs have higher affinity, it is believed that 
they alter the balance, inducing more TCRs to bind and shift the signalling across the 
threshold towards activation. Despite the concept being very popular in explaining the T 
cell response [67-69], it only seems to hold true to thymocytes [70, 71]. The existence of 
significant contradictory evidence suggests affinity may play a role, but it is not the only 
factor [45, 51, 72]. Therefore, in the human body, it is likely that some amount of tonic 
signalling is induced by receptor occupancy due to its tuning at the thymic selection level, 
but the knowledge that a single antigenic MHC binding event induces responses [47, 48] 
brings to question this mechanism playing a significant role in pathogen clearance. 
2.3.2 Kinetic segregation 
The concept of kinetic segregation originated as an alternative model based on the 
observation that receptor-ligand interaction of similar sizes segregated into small 
microdomains upon T cell activation during immunological synapse formation [73]. It is 
known that the membrane-bound phosphatase CD45, which lacks any known ligand, 
regulates the kinase activity of Lck [61, 74]. Due to its large ectodomain (~45nm) and the 
relatively small intermembrane distance of the TCR:MHC complex (~15nm), passive 
minimization of membrane bending energy leads to segregation of CD45 from TCR:MHC 
complexes over time [75, 76]. This isolation promotes kinase restricted zones where high 
kinase activity phosphorylates CD3 intracellular tails, resulting in T cell signalling. As 
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evidence for this mechanism, deletion or shrinking of extracellular CD45 domains has been 
shown to reduce TCR-CD45 isolation and eliminate T cell activation [76]. Due to the low 
number of antigenic pMHC on the surface of cells, it is unlikely to be the primary factor in 
initial TCR triggering. Kinetic segregation likely plays a role in immunological synapse 
formation and propagation of TCR signalling, adding a signalling amplification layer 
leading to full T cell activation, but does not provide the means for the initial triggering 
events.  
2.3.3 Kinetic proofreading and extensions 
TCR recognition of antigenic peptides exhibits qualities of high specificity and 
sensitivity. As TCRs scan the surface of an APC, they will experience lots of noise in the 
form of self-pMHC, but will only respond after encountering antigen; this is termed 
sensitivity, as the TCR must be extremely sensitive to the presence of antigen to respond 
above the noise [21, 47, 77].  Additionally, a single amino acid point mutation in the peptide 
fragment can also completely change the response – that is, the TCR responds specifically 
for a certain pMHC and will not trigger when it does not engage antigen peptide [78]. 
Although kinetic segregation and receptor occupancy models may be instrumental 
in propagating TCR signalling, the initial triggering mechanism, i.e. the first triggering 
event leading to activation, is still under debate. The first attempt at modelling this 
mechanism was the kinetic proofreading mechanism adapted by McKeithan [79] from 
DNA replication models. He suggested that upon binding, modifications began occurring 
to the TCR at a specific rate. Once a significant number of modifications had been made, 
the TCR was considered fully active. If the TCR:pMHC complex dissociates before full 
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activation, the TCR reverts to an unmodified resting state. In this simple model, specificity 
is increased with higher modification number, but at the cost of sensitivity due to the 
stochastic nature of receptor-ligand dissociation. 
As a consequence of this model, the primary kinetic factor in TCR signaling would 
be the rate of dissociation. The model suggests that a low off rate interaction should be able 
to produce a signal, whereas a high off rate ligand should not. However, this has been found 
incomplete, as 2D kinetic measurements of the off rates of ligands of differential potency 
have shown little variation [80, 81]. The model has been modified to include rebinding to 
include the influence of on rate [82], feedback loops including downstream signaling 
molecules [83-85], effector responses [86], and conformational modifications [87]. Each 
adds to the complexity of the model, but provides a new framework for antigen sensitivity 
and specificity. Likely, the truth lies in some form of kinetic proofreading, but not at the 
simplistic level presented by McKeithan. Because of the strength of this model, an 
extension of the kinetic proofreading model will be utilized in future chapters.  
2.3.4 Role of force in antigen recognition  
Mechanical forces have been known to be act on receptors to induce responses, a 
concept broadly termed as mechanotransduction. The concept of mechanical force in TCR 
triggering was first proposed as a mechanism to resolve the complex sensitivity/specificity 
interplay by Ma and colleagues in 2008 [88]. Experimental and structural evidence has 
shown that mechanical pulling and/or torques on the TCR can induce signalling [89-93]. 
Additionally, agonist TCR:pMHC bonds have been shown to have increased lifetime with 
force, a counterintuitive phenomenon called a catch bond [94], which could increase the 
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bond duration for kinetic proofreading [92]. In fact, signalling could not be provoked in 
the absence of force applied to the bonds and was specific to the pMHC interaction [92, 
93]. It is believed that force on the TCR:pMHC translates through the CD3 ectodomains 
for intracellular ITAM dissociation from the membrane, resulting in phosphorylation and 
TCR activation [95]. The origins of mechanical stimulation in vivo may be the result of 
cytoskeletal rearrangement [96] or membrane fluctuations [97]. Although 
mechanotransduction may be a significant player in TCR triggering and cell activation, the 
field is still in its infancy; not much is understood about the specifics of this process.  
2.3.5 Models for the role for coreceptors in antigen discrimination 
The coreceptors CD4 and CD8 are both able to bind MHC independent of TCR 
binding, albeit very weakly [98, 99]. Each coreceptor can be bound intracellularly to Lck 
[100, 101]. It is believed that the coreceptors act to either stabilize TCR:MHC complexes 
[99, 102, 103], trap MHC close to membranes [104], or provide a mechanism for Lck 
delivery and propagate signalling [105, 106]. There are several caveats to these models. 
Coreceptor binding is not necessarily required for T cell activation [107] and can be 
dominated by strong agonist pMHCs [108]. Additionally, TCRs are activated in cytosolic 
Lck, not the Lck bound to coreceptor [109]. However, it is clear that both coreceptors bind 
to the TCR:pMHC complex and are required for in vivo activation.  
Although there are a significant number of TCR binding/signalling simulation 
analyses, few involve coreceptors. Due to the presence of intracellular Lck which can bind 
CD3 ITAMs, coreceptors have the ability to form a pseudo-dimer of dimers (PDD) where 
there are three reversible bonds (TCR:MHC, CD8:MHC, Lck:CD3) playing a role to 
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stabilize the complex through close proximity. Chakraborty and colleagues suggested 
through modelling that this effect was minimal, but its lacks supporting experimental 
evidence [110]. Other recent models have suggested that the role of coreceptors relies 
solely on its ability to deliver Lck [111, 112]; similar to kinetic proofreading, the 
TCR:pMHC interaction discriminates by lasting long enough to “scan” coreceptors for the 
presence of Lck. Once one is found, the T cell activates. However, this model suffers from 
the same sensitivity/specificity exchange as kinetic proofreading models due to its heavy 
reliance on TCR:pMHC bond lifetime. At this time, the true role of CD8 in TCR antigen 
recognition is incompletely understood. 
2.4 Motivation and significance of research 
As summarized previously, the importance of the TCR in the human body cannot be 
understated. T cells play a substantial role in the adaptive immune system, and their TCR 
is the primary molecule in unleashing the T cell response. The motivation for this study is 
simple. There are many models of TCR triggering the initial cellular response, but none 
can adequately explain the high sensitivity and specificity of antigen recognition at the 
single pMHC level. Comprehensive understanding of this process is critical to initiating 
new waves of safer and better-informed immunotherapies. We believe that some critical 
information encoded in the TCR triggering process was previously not accessible by 
traditional assays. By using novel biophysical readouts of sensitive binding assays as a 
reflection of the underlying biological process, this study uncovers mechanisms 
surrounding the unique specificity and sensitivity in TCR antigen recognition through 
combined experimental and simulation-based analyses.  
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CHAPTER 3. EXPERIMENTAL MATERIALS AND METHODS 
3.1 Cells and proteins 
The TCR-deficient J.RT3-T3.5 Jurkat cell line transfected with 1E6 TCR (1E6-J) 
and the associated biotinylated pMHC were gifts from Dr. David Cole. 1E6-J cells were 
expanded a media of RPMI 1640 with L-glutamine supplemented with 10% fetal bovine 
serium and 1unit/mL penicillin/streptomycin (R10) in 37C, 5% CO2, then stored in R10 
containing 10% dimethyl sulfoxide (DMSO) at -80C or liquid nitrogen for future use. 
Cells were thawed and rested in R10 for a minimum of 24 hours before use. Cultures were 
maintained in 37C, 5% CO2, for up to two weeks. Media was changed every 48-72 hours 
to maintain 0.2-1 million cells/mL. Cells were taken as needed for experiments. 
Biotinylated pMHC was allocated into 20g/mL vials, 10L, in phosphate buffer saline 
(PBS) with 1% BSA and stored at -80C and diluted with the same solution for coating 
purposes.  
3.2 Bead preparation  
Streptavidin-coated beads (SA beads) were prepared similarly to biomembrane force 
probe beads in [80]. 8.1 m borosilicate glass beads were first covalently coupled with 
mercapto-propyltrimethoxy silane which was then covalently linked to tetravalent 
streptavidin-maleimide in PBS by overnight incubation at room temperature. Once 
prepared, SA beads were stored at 4C in HEPES buffer with 1% BSA and taken as needed. 
SA beads were then incubated with biotinylated pMHCs for 1h at room temperature and 
then resuspended in HEPES buffer with 1% BSA. 
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3.3 Site density measurement 
Site densities for TCR and pMHC were measured using flow cytometry and PE 
conjugated antibodies for the specific molecules [80]. pMHC: BB7.2, BD Pharmingen 
Cat#558570; TCR: IP26, Biolegend, Cat#306708. Cells and beads were incubated with 
antibodies at 10μg/ml in 50μl PBS without calcium and magnesium, 1% BSA, 25mM 
HEPES buffer at 4°C for 30min; The fluorescent intensity was measured by the BD LSR 
II flow cytometer and calibrated by the BD QuantiBRITE PE standard beads (BD 
Biosciences). To determine site densities, the total amount of surface protein was divided 
by the surface area of the cell or bead. 
3.4 Microcantilever preparation and calibration 
Microcantilever wafers were purchased from Bruker (OBL-10). Microcantilevers 
were cleaned in piranha solution (3:1 high concentration sulfuric acid to 30% hydrogen 
peroxide) for 30 minutes, rinsed in deionized (DI) water, placed in an ethanol bath for 5 
minutes, and finally rinsed again in DI water. Cantilevers were functionalized in a 
400μg/mL biotinylated BSA (Sigma Aldrich A8549) in PBS overnight in 37C. After 
incubation, cantilevers were washed and placed in filtered PBS and stored for future use at 
4C for up to one week. 
To calibrate the microcantilevers, an SA glass bead was picked up by the 
micropipette of the HAFM and aligned with the tip of the microcantilever. Piezo actuation 
of the micropipette moved the bead with constant velocity while the signal from the 
photodiode was recorded. The slope of the resulting distance (measured by the capacitive 
feedback sensor on the piezo) vs. signal curve was measured to calibrate photodiode 
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sensitivity to distance. Cantilever stiffness was then measured by the thermal fluctuation 
method [113]. 
3.5 Statistical analyses 
Statistics were performed as noted in either MathWorks Matlab (R2015b), Python 
(Spyder 3.2.4) Microsoft Excel, or GraphPad Prism. Statistical analyses for calibration of 
simulation parameters was performed in R statistical packages. The process is currently 
under review [114].  
Linear regression was performed in Matlab (R2015b) using first and second order 
covariates of the contact and waiting times and their effects with previous adhesion score. 
Those whose coefficients were not significantly non-zero were eliminated one at a time in 
order of least significant until all covariant coefficients were significantly non-zero. 
3.6 Dynamic micropipette assay using HAFM 
The procedure is outlined in Section 4.3.2. Briefly, a bead coated in the ligand is 
adhered to the microcantilever along the center axis through superfluous SA-biotin 
interactions. A cell is then aspirated by the micropipette and brought into contact with the 
bead. The indentation force was controlled between 20-30pN assuming a cantilever 
stiffness of 4pN/nm. The cell was then held in contact for a period of time between the 
uniform interval 0.25-5s. The cell was then retracted by piezo control. A bond was 
identified by a fast dissociation step by the photodiode signal. The cell was then permitted 
to rest for another period on the interval 0.25-5s, which was adjusted for retraction and 
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approach times accordingly. The experiments were limited to 300 contacts. Cells which 
tethered extensively or did not reach 150 contacts were removed from analysis.     
3.7 Lck inhibition treatment 
The lyophilized powder for small molecule inhibitor of Lck, CAS 213743-31-8, was 
purchased from Sigma-Aldrich (428205-M), dissolved in DMSO, and stored in aliquots 
for future use at 4C. 500,000 cells/mL were treated in 4 or 20μM of the inhibitor or vehicle 
control in L15 media supplemented with 1% BSA and HEPES buffer for 30 minutes at 
room temperature, then placed in the HAFM chamber. Experiments were performed in the 
continuous presence of the inhibitor or vehicle control for no more than 2h.  
3.8 Cholesterol oxidase treatment 
Cholesterol oxidase lyophilized powder was purchased from Sigma-Aldrich, 
dissolved in PBS, and stored in aliquots for future use at -20C. 500,000 cells/mL were 
treated in 1U/mL of the inhibitor or vehicle control in L15 media supplemented with 1% 
BSA and HEPES buffer for 1h at 37C, then placed in the HAFM chamber. Experiments 
were performed in the continuous presence of cholesterol oxidase for no more than 2h.  
3.9 Cholesterol sulfate treatment 
Sodium cholesteryl sulfate was purchased from Sigma-Aldrich (C9523-25MG), 
dissolved in DMSO, and stored in aliquots for future use at -20C. 500,000 cells/mL were 
treated in the noted concentrations of cholesterol sulfate or control in L15 media 
supplemented with 1% lipid-free BSA and HEPES for 1h at 37C, then placed in the 
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HAFM chamber. Experiments were performed in the continuous presence of cholesterol 
oxidase for no more than 2h. 
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CHAPTER 4. DEVELOPMENT AND VALIDATION OF A 
HORIZONTAL ATOMIC FORCE MICROSCOPE 
4.1 Background 
Atomic Force Microscopy (AFM), a form of scanning probe microscopy, is a 
renowned instrumentation concept used to measure extremely small displacements (<1nm 
resolution) or forces (~1pN resolution). The most rudimentary AFM is composed of a 
microcantilever/laser/photodiode system. The laser is focused on the back of a 
microcantilever and reflected back to a photodiode. When the cantilever is deflected, the 
laser reflection will shift on the photodiode and an intensity change is measured (Figure 2). 
Within a small range of displacement, the intensity change on the photodiode is linearly 
proportional to the displacement. If desired, this displacement can be converted to force by 
calibration of the cantilever stiffness.  
 
Figure 2. Principle components of atomic force microscopy 
 
A laser is focused onto the back of a microcantilever. The reflection is measured on a 
photodiode of two sides (although four is also common for detection of torsion 
components). Movement of the cantilever in either direction will correspondingly move 
the laser reflection. This displacement can be calibrated to the signal. Signals can be 
measured at extremely high rates, limited only by computational resources. 
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AFMs have two general functions although others have been proposed. Primarily, 
commercial AFMs are used as imaging tools to measure a range of surface topographies, 
from biological to mechanical materials. The result is a 3D surface mapping of the material. 
However, they can be adapted to function as molecular force probes, which are important 
to the study of mechanical responses of receptor-ligand interactions. In these assays, a 
piezo-electric motor brings a functionalized AFM tip into and out of contact with the 
sample. With such a device, the dynamics of specific receptor-ligand interactions can be 
examined under mechanical force.  
There are several methods of measuring similar kinetic properties of receptor-
ligands interactions at the single molecule level. In essence, the method which can be used 
relies on the origins of the receptor-ligand pair, summarized in Table 1, although it must 
be noted that this list is not entirely comprehensive. In an ordinary AFM system, both 
molecules need to be purified and usually functionalized to the microcantilever through 
specific interactions; neither the receptor nor ligand can reside in the cellular context. Cell-
purified molecule dynamics (where one molecule is in the cellular context, the other is 
purified) cannot easily be performed on the AFM. If a cell is adherent and can reach high 
confluence on the plate, it is possible to perform on AFM. Lastly, zero-force assays 
(thermal fluctuation) or measuring the interaction of two cells is nearly impossible.  
 26 
Table 1. Comparison of single molecule measurement techniques and their assays 
 
 Adaptations of the AFM concept have made some of these assays more accessible. 
The addition of an objective and camera on the top of an AFM has provided the means of 
mounting cells or purified molecules onto cantilevers while being able to control their 
contact onto plated cells [115-118]. Other adaptations of added another camera/objective 
on the side to perform microscopy of the cells during and after contact [119, 120]. Recently, 
Ounkomol and colleagues have developed a new form of Horizontal Atomic Force 
Microscopy (HAFM) in which they mount the AFM under a microscope and replace the 
sample plane with micropipette aspiration control [121, 122]. Although Ounkomol’s 
measurements primarily focused on mechanical force interactions, this setup had 
significant potential in many different assays outside the typical AFM scope (Table 1, 
Figure 3). We realized this system had the capacity to perform and automate the tedious 
micropipette assay [123]. Due to the nature of an automated system, the HAFM also has 
the potential to mediate long-term kinetic probing assays on cells to elucidate mechanisms 
involved in regulation of kinetics due to signaling. With these assays in mind, we decided 
to develop a HAFM and validate its utility.  
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Figure 3. Diagram of different HAFM molecular origins 
 
4.2 Development of instrumentation 
There are two different components to instrument design – hardware and software. 
Both were designed in tandem to operate the many different assays of the HAFM. 
4.2.1 Hardware design 
As mentioned earlier, a HAFM consists of several key components, but the physical 
system requires additional manipulation, control, and noise isolation components. Of the 
components, many were purchased from reliable suppliers (Table 2) with the exception the 
custom-designed hardware, consisting of the micropipette, photodiode board, and many 
machined components.  
Table 2. HAFM primary components 
Quantity Manufacturer Item Description Item # 
1 TMC Tabletop Vibration Isolator  64-314 
1 Dell Computer/Monitor Optiplex 
1 NI PCI card for A/D conversion PCIe-6321 
1 NI Input/Output BNC connector 
block 
BNC-2110  
The HAFM can be used to perform force/displacement assays in the context of (A) 
purified molecule-purified molecule interactions, (B) purified molecule-cell 
interactions, (C) or cell-cell interactions.  
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1 Newport Micromanipulator 461-XYZ-M 
3 Newport Micro actuators DM-13B 
3 Warner MP holder 64-1261 
1 OZ Optics Laser source attenuator BB-500-11-670-4/125-
S-40-3S3S-3-0.5 
1 OZ Optics Laser source FOSS-21-3S-4/125-670-
S-0.9 
1 OZ Optics Laser lens LPF-04-670-4/125-S-
1.9-50-18AS-40-3S-3-1 
2 ThorLabs Side camera DCC1645C 
1 Computar Side camera lens MLH-10X 
1 Warner micropipette holder 64-0218, Model #MHH-
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1 Analog Devices Photodiode AD8251 
3 Newport Micromanipulator MS-500-XYZ 
1 Edmund Optics  Laser Filter #65-657 
2 Unknown 
(Chinese 
XY 30X30mm linear stage LY30-L 
1 Edmund Optics 5mm, Rhomboid Prism, VIS 0 
Coated 
#47-806 
1 PI Linear piezo electric motor with 
capacitive feedback 
P-753.12C 
1 PI Piezo electric controller E-509.C1, E-505.00 
1 Nikon Microscope Diaphot 
1 Olympus LWD Objective ULWD CDPlan 40PL 
0.50 160/0-2 
The photodiode board was built in-house. The photodiode itself was purchased 
from Analog Devices (AD8251) and was selected for its excellent performance in drift, 
power, noise, and response time. The circuitry of the board itself was designed by Dr. Fang 
Kong with assistance from the electrical shop at Georgia Institute of Technology (Figure 




Figure 4. Photodiode board circuitry 
 
  A major hindrance to the design of a HAFM is space – a significant number of 
components must be confined under a microscope. A Solidworks representation of the 
device was outlined to assist with spatial restrictions and develop machined brackets and 
the chamber (Figure 5A). The chamber development required several iterations. The laser 
path penetrates through a Plexiglas piece, referred to as the cantilever mount, which is 
designed with a slight incline (7.5) to avoid overlapping laser interference from the two 
reflective surfaces (air-Plexiglas transition, back of cantilever). For ease of microcantilever 
placement, a clamp was built-in to hold the microcantilever in place against the cantilever 
mount and slots were used to slide pieces together. Fasteners for coverslips are made of 
non-conductive materials for the isolation of metal clamps to heat-conducting glass (used 
for temperature control) which requires electrical current. A picture of a portion of the 
completed instrumentation can be seen in Figure 5B. 
Designed by Dr. Fang Kong 
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Figure 5. HAFM hardware development requires maximal use of space 
 
4.2.2 Software libraries 
Control of the HAFM was developed in Labview with used of State Diagram 
packages, and analysis was developed in either Matlab or Labview. Programs were written 
for calibration of photodiode sensitivity, spring constant calibration, micropipette assay, 
rupture force assay, force clamp assay, and data analysis. More about the outlines of the 
algorithms will be discussed in the validation section or in Experimental materials and 
methods. 
4.3 Validation of instrumentation 
4.3.1 Hallmarks of AFM 
HAFM should have the same functional hallmarks as the standard AFM. First, 
displacement of the microcantilever tip should be linearly proportional to the signal change 
on the photodiode. Secondly, the power spectrum of thermal noise of a cantilever should 
have a resonance peak, fitting to the description of it as a simple harmonic oscillator [113]. 
(A) Solidworks representation of planned HAFM hardware under microscope. White 
arrows point to specific components. (B) Picture of completed hardware under 
microscope. Penny for scale.  
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To test the linear displacement, a stiff polystyrene glass bead was brought into contact with 
the microcantilever tip using piezo control. Capacitive feedback from the piezo motor 
simultaneously monitors displacement. Plotting the photodiode voltage against the 
displacement from the feedback sensor gives a reliable linear response, which is repeatable 
and consistent at different time intervals (Figure 6A). Examination of the thermal 
fluctuation power spectrum also gave the characteristic resonant peak (Figure 6B).  
 
Figure 6. AFM signal hallmarks 
 
 
4.3.2 Micropipette assay 
The micropipette assay was developed as a method to determine kinetics of two 
membrane-bound proteins [123]. In the traditional form of micropipette, a Red Blood Cell 
(RBC) is coated in the ligand of interest and brought into contact with its receptor for a 
controlled duration by piezo control. The cells are then separated through retraction of the 
pipette. If there is a bond at the end of contact, a small deflection is seen at the RBC 
interface; if there is no bond, a deflection of the RBC is not seen. Repeating this cycle for 
(A) Linear voltage vs. displacement response from contacting a glass bead driven by 
piezo actuation. Red curve is actual signal. Black line represents linear slope for 
sensitivity calibration. (B) Power spectral density curve of free signal, averaged analysis 
of 200 runs from 4096 samples at 80000 Hz, showing standard resonance peak for a soft 
cantilever, used for calculation of spring constant once sensitivity is calibrated. 
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many touches across different contact times results in sequences which can be converted 
into adhesion frequencies, or probabilities of adhesion (Pa), which are reflective of the 
kinetic characteristics of the receptor-ligand interaction. 
There are several limitations to the traditional micropipette assay. First, there exists 
human error in bond identification. In some receptor-ligand interactions, the bonds are very 
strong and deflections are easily discerned. However, this is not the case in many 
interactions which are measured where bonds may be weaker, and there is the possibility 
of misidentification of events. This can exceptionally difficult when there is more than one 
bond state and requires significant training and experience.  
Secondly, the Pa depends considerably on contact area (amount of area in which the 
molecules can interact). Because of pipette drift, corrections are required by the user to 
maintain constant contact area. Additionally, this contact area can vary from user to user 
depending on preferences, so results are sometimes difficult to compare amongst different 
users. This can also be rectified by experience and training. However, it is still a source of 
uncontrollable error in the micropipette assay.  
Lastly, it is nearly impossible to maintain a tightly controlled sequence of events. 
Due to pipette drift and the difficulty of general distractions during the several hours 
required for the assay, events are not always measured in succession – pauses may be made 
and events may be missed. This is perfectly acceptable if the sequence of events is 
Bernoulli which is the case for many receptor-ligand interactions; however, as we will see 
in CHAPTER 5, sometimes the sequence is Markovian. Additionally, if the user requires 
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dynamic inputs to the program, these missed events become critical. Analysis of the 
sequence is therefore disturbed by assay constraints on the user. 
The HAFM has the capacity to rectify these problem areas through use of signal 
recorded bond detection, controlled impact of cell contact, and robustness of the assay 
performed on the HAFM, respectively. To automate this process, beads coated in the ligand 
of interest can be adhered to the microcantilever through specific interactions. Several can 
be loaded for fast transition (see Figure 7 microscope view, up to three beads can be placed 
simultaneously without signal aberration). The target cell is aspirated by the HAFM 
micropipette system. Upon initialization of the program, the cell is driven into contact with 
the ligand-coated bead to a user-inputted signal deflection, i.e. force, through piezo motor 
control. The surfaces are permitted to interact for a randomly selected contact period 
defined between a specific interval, then separated to a distance for another randomly 
selected waiting period between a specifically defined interval. This cycle can be repeated 
for hundreds of contacts or until an error in the system occurs. Simultaneously, the 
photodiode signal is recorded at a defined rate, allowing each contact cycle to be analysed 
at a later point.  
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This method of micropipette serves to negate the previously described errors 
associated with traditional micropipette assays. The detection of an event outcome (bond 
or no bond) is straightforward (Figure 7), even for weak interactions due to the sensitivity 
of AFM measurements. Unless severe misalignment occurs, the impact force controls a 
constant contact area over the course of an experiment assuming constant viscoelastic 
properties of the cell. Lastly, the sequence of events is retained due to automated control 
of the system and lack of user intervention (Figure 8). 
Beads coated in the ligand of interest are adhered to the microcantilever through specific 
interactions. A typical microscope view is provided with a cartoon for clarity. The cell 
and its receptor can be brought into contact with the beads for controlled, automated 
contact periods. Two example events are shown. Bond events (arrow with *) can be 
discerned from no-bond (arrow, no *) events through cantilever signal deflection. 
Contact times (CT) and waiting times (WT) can be randomly selected. The events can 
be compiled and analyzed in a similar fashion to traditional micropipette data. 
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Figure 8. HAFM micropipette data stability 
 
4.3.3 Force clamp and rupture force assays 
The force clamp and rupture force assays have been shown to be a powerful tool in 
understanding the response of cell surface receptors to mechanical stimulation. In the force 
clamp assay, a single receptor-ligand bond is pulled to a specific force level and permitted 
to exist until it dissociates. Because these lifetimes are highly stochastic, lifetimes over 
many different events are compiled for analysis. Rupture force assays are a simple 
extension of force clamp assays where the force level is set to infinity and the bond is 
simply pulled until rupture; the output is the force at which the bond dissociates. This is no 
longer a widely-used technique due to the necessity for pulling at several different force 
loading rates for significant analysis of the rupture dynamics and the effects of viscous 
drag forces at high loading rates.  
As mentioned previously, there are several instruments which can perform 
mechanical force assays with purified molecules, but the HAFM has the added advantage 
Unfiltered raw data from HAFM. Successive contacts are shown across ~2 minutes. 
Bonds are marked by red asterisks.  
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of being able to perform cell-cell force assays. Although many of these systems claim force 
clamp capabilities, the feedback systems required to clamp at constant force are limited to 
a distance clamp without closed feedback; the HAFM, due to its fast acquisition rates, is 
able to provide closed-loop force clamping capabilities to adjust for any disturbances in 
force level (signal aberrations, cell or molecule relaxation, molecular species changes, 
cytoskeletal rearrangement, etc.).  
To demonstrate these capabilities, we used a Jurkat cell line transfected with 1E6 
human TCR against several different pMHC ligands, similar to the setup seen in Figure 
3B. A demonstration of the force clamp cycle is shown in Figure 9A where the cell is 
brought into contact with the bead, permitted to interact for a period of time to allow for 
bond formation, then retracted to a defined force level which is maintained until bond 
dissociation. For the duration of a long lifetime bond, the piezo must continuously adjust 
to maintain force level (Figure 9A, bottom panel). Three different ligands of different 
potency were tested for their kinetic response to mechanical stimulation through the force 
clamp assay (Figure 9B-D). Several hundred bond lifetimes across various forces were 
measured and binned into lifetime vs. force curves. Weak ligand ALW showed a slip-bond, 
whereas the strong ligands (YQF, RQF-I) had catch bonds. This concept is consistent with 




Figure 9. Demonstration of HAFM force clamp assay 
 
To demonstrate the HAFM modality of cell-cell force experiments, the interaction 
between CD222 and PD-L1 was tested. The CD222:PD-L1 interaction relies heavily on 
glycosylation, so it was thought best to examine its interaction kinetics in a native system. 
Therefore, we mounted a CHO cell transfected with CD222 onto the microcantilever and 
brought it into contact with a micropipette aspirated HEK cell transfected with CD222 
ligand PD-L1; these two cells lines of different species were used to negate some of the 
background adhesion contributed by other molecules. To examine implications of the 
receptor-ligand interaction on overall cell-cell adhesion, we performed experiments with 
(A) Example raw data from the HAFM showing approach, contact, clamp, and 
dissociation phases of a force clamp assay cycle. (B-D) Compiled data for force-lifetime 
curves from 1E6 TCR vs. three different ligands (ALW, YQF, RQF-I)  
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and without the addition of a specific blocking antibody. The cells were brought into 
contact for either a short or long duration, then pulled until no bonds remained.  
Two methods were used to quantify the strength of the intercellular adhesion – 
rupture energy and peak rupture force. The peak rupture force is the maximum force 
reached after separation. The rupture energy is how much energy the piezo required to pull 
the cells apart; this is calculated by integrating the force-extension profile over the entire 
separation period. An automated process was used to quantify both metrics, with similar 
results compared to an unbiased human analysis (Figure 10A). As expected, longer contact 
times permitted more bond formation and therefore stronger intercellular adhesion. 
However, despite the addition of a blocking antibody inhibiting the interaction, no 
difference was seen between the two conditions for either contact time or method of 
quantification (Figure 10B-D).  
 
Figure 10. HAFM cell-cell force separation characteristics 
 
HAFM was used to measure the mechanical separation of a CHO cell transfected with 
CD222 and a HEK cell transfected with ligand PD-L1. (A) Validation between 
algorithmic and user determination of rupture force. (B,C) Rupture energy required to 
break cells given 0.25s (B) and 1s (C) contact. (D,E) Maximum rupture force upon cell 
separation given 0.25s (D) and 1s (E) contact. 
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There are two possible explanations for the lack of significant differences in the 
presence of a blocking antibody. First, the PD-L1:CD222 interaction is not well 
characterized. It is possible that the antibody did not inhibit all interaction sites, although 
the antibody addition partially blocking tetramer staining. Secondly, we attempted to 
minimize background adhesion through use of cell lines of different origins, but some still 
remained. It is likely that the contribution of PD-L1:CD222 was minimal compared to 
background.  
4.4 Discussion and future directions 
In this chapter, the HAFM instrumentation was described and demonstrated in several 
different modalities. There are several components to the device which could be improved. 
First, although the imaging platform of the microscope is used, very little is utilized at this 
time. This is in part due to the lack of a filter to isolate only laser-specific passing 
wavelengths from the microscope light source. Currently, this is due to spatial 
considerations requiring a custom-designed photodiode board housing. Additionally, due 
to the size of the microcantilever wafer, the image plane must be approximately 2mm from 
the bottom of the coverslip. This requires a long working distance objective with low 
resolution. Decreasing unnecessary wafer thickness by milling could reduce the focal 
length, but may impact microcantilever function. Secondly, although there is significant 
manipulation in laser plane, attaching a third dimension of micromanipulation for better 
control over laser focus would be an improvement; currently it is consigned to slots 
designed into the housing. Lastly, although the software acquisition rate is ~1000Hz, it 
could be improved through an optimized parallel data acquisition/processing and 
refinement of algorithms. 
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There are several limitations to the HAFM that cannot be overcome through 
instrument development. First, signal noise is relatively high (Figure 9A) resulting in lower 
signal resolution. This makes forces below 5pN extremely difficult to maintain, and 
thermal fluctuation assays for zero force kinetic measurements very difficult. The 
Biomembrane Force Probe (BFP) or optical trap may be better suited for low force 
measurements. Additionally, as demonstrated in Section 4.3.3, it is difficult to perform 
intercellular adhesion to examine the impact of specific receptor-ligand interaction. 
Background adhesion is very high, and there are limitations to availability of specific 
blocking antibodies or molecular mutations. Therefore, if these assays are to be developed 
further, the correct target interaction should be investigated; this limits selection to 
interactions with a significant impact on intercellular adhesion and adequate reagent 
availability. 
Despite the small improvements that can be made to the instrument, it is highly 
functional and can perform many different assays. The HAFM micropipette assay itself 
has many advantages in automation and accuracy over the traditional micropipette. This 
functionality will be extensively used in the CHAPTER 5 to measure long sequences of 
adhesions. Additionally, future experiments are suggested to fully develop and validate the 
model proposed in CHAPTER 6 which rely on the signal stability of the HAFM. 
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CHAPTER 5. TRANSIENT LIGAND MEMORY IN TCR 
ANTIGEN RECOGNITION 
5.1 Background 
It has long been known that T cells utilize their T Cell Receptor (TCR) to identify 
and promote a response to recognition of antigenic pMHC [9-11]. This process has an 
uncanny combination of both sensitivity and discrimination, as it is sensitive enough to 
induce a response to as little as a single antigenic pMHC interaction while still maintaining 
ample discrimination power from the several magnitudes greater number of self-peptides 
[51].  
The strength of the T cell response has generally correlated very well to the 
intermolecular affinity of TCR to pMHC with 2D measurements being slightly more 
sensitive than their 3D counterparts [80]. Models have been envisioned to account for this 
unique set of abilities, conceptually modeled after kinetic proofreading which heavily relies 
on the interaction off-rate [79]. With the exception of a few conceptual models [124], 
binding of TCR to pMHC has been thought to occur with fixed kinetic rates or minimally 
affected over the course of APC contact. Recent research has shown that kinetic rates may 
been affected by cholesterol binding [58-60] or over longer periods of time near 
immunological synapse formation [87, 125], but little emphasis has been put on 
TCR:pMHC binding during the critical initial triggering phase. A better understanding of 
these early events will help to understand the complex signaling dynamics at later time 
points. 
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Previously, it has been shown that the TCR:pMHC  interaction has significantly 
upregulated periods of adhesion throughout the adhesion frequency assay [126] as 
quantified by the memory index. This positive memory index is a Markovian process 
reflective of periods of increased sensitivity to antigen at the molecular level which may 
play a role in the antigen recognition process. In practice, this value is simply the increase 
in binding probability following a binding event. However, in a cellular context, this 
increase in binding probability can be reflective of many different processes, including 
signaling modifications or cytoskeletal rearrangement. This discovery was largely 
unnoticed by the TCR field due to the packaging of the paper as a phenomenon of general 
receptor-ligand interactions with little focus on the TCR itself. 
Several methods were applied to determine the presence of ligand memory in TCR 
binding and its mechanistic origins. To see if the molecules themselves had conformational 
changes due to binding in the absence of its cellular environment that resulted in this 
behavior, we analyzed several sets of data from purified TCR:pMHC systems. 
Additionally, we verified that a positive memory index exists in many different 
TCR:pMHC systems, both mouse and human. Due to the inherent stochasticity in the 
adhesion frequency assay and subsequent high variation in the memory index, we also 
developed a randomized 2D micropipette adhesion frequency approach utilizing the 
HAFM to measure TCR:pMHC adhesion frequency over an extended period of time (~20-
30minutes). This technique was utilized to examine the role of adhesion memory in TCR 
antigen recognition and the time scales at which it operates. Finally, simulation-based 
analysis of a mechanism explaining memory will be presented. 
5.2 Memory index  
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As a concept, the memory index arose from the observation that many bonds occurred 
in series in some micropipette assay experiments, or what was seen as “clusters” of bonds 
during analysis. In analysis of micropipette experiments for determination of kinetics, each 
event in the sequence is assumed to be independent and identically distributed (i.i.d.), i.e. 
the sequence is Bernoulli. Clusters of bonds are not representative of a Bernoulli sequence. 
If these events are not i.i.d., it was thought that this may be representative of some behavior 
of the cellular environment or the molecules themselves. Two methods were developed to 
quantify this “clustering” and termed the memory index [126]. In either method, the exact 
value of the memory index is defined as the increase in the probability of adhesion if there 
was a bond in the previous contact versus the case where there was no bond in a previous 
contact.  
The first method was termed the direct method. In this method, the events in an entire 
sequence of contacts are divided into 4 different cases: n00, n01, n10, n11 with the subscripts 
representing a two sequential contacts with 0 for no bond, 1 for a bond. For example, n01 
is the total number of events in the sequence where there was no bond followed by a bond; 
n10 is the total number of events where there is a bond followed by no bond, and so forth. 
The probability of adhesion after a bond would therefore be p11 = n11/(n11+n10), and 
similarly, the probability of adhesion after no bond would be p01 = n01/(n01+n00). The 
memory index can therefore be calculated as p11-p01. If the sequence is Bernoulli, the 
memory index should be zero. 
The second method of memory index quantification is termed the cluster method. In 
this method, the size of the clusters was fit to a Markovian model. For instance, seven 
bonds in a row is a cluster of size seven. The total number of clusters of each size were 
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calculated for an entire sequence. The number of clusters of each size were then fit to the 
Markovian model.  
The direct and cluster methods have been shown to have comparable results in 
measuring the memory index. More description of the cluster model calculation and 
comparison between the two can be found in [126]. However, the cluster method has lower 
resolution; many events are binned into a single point and fit to the model. The direct 
method is therefore used throughout the rest of the study for the sake of consistency. 
5.3 Verification of TCR memory in cellular environment 
To determine if this phenomenon results from the TCR in its native cellular 
environment, we analyzed data from several systems to verify its replicability and validate 
its presence. Previously, TCR memory had only been demonstrated in a transgenic mouse 
system (OT-1:OVA TCR:pMHC) [126]. Measurements made by Dr. Jun Huang on a panel 
of peptides of different potency for the OT-1 system confirmed TCR memory for the strong 
OVA peptide as well demonstrated memory in weaker peptides (Figure 11A). Additionally, 
measurements made by Dr. Jin-sung Hong of the 3L2 transgenic TCR mouse system 
(recognizing a hemoglobin (Hb) peptide fragment bound to MHCII) indicated that TCR 
memory occurs in class II MHC system (Figure 11B). Contrastingly, the mouse MHC class 
I and II systems showed different trends of memory index:ligand potency dependence – 
the 3L2 system showed no dependence on ligand potency, whereas the OT-1 system 
peaked at a mid-range potency ligand G4 and dropped to zero for very weak ligand R4. 
This is likely due to the difference in micropipette assay styles of different people (see 
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discussion in Section 4.3.2), but could also be an artifact of binning data of different contact 
and waiting times into a single measurement or high variance in the measurement.  
 
Figure 11. Memory index for several TCR:pMHC systems 
 
 
To limit variance in data collection and test a human system for TCR ligand memory, 
we performed the micropipette assay with more contacts to decrease memory variance on 
a clonally expanded 1E6 TCR system against a panel of APLs. The 1E6 TCR recognizes a 
pre-proinsulin-derived peptide (ALW) loaded onto HLA-A2 pMHC (class I); the cells were 
isolated from a patient with type I diabetes and a panel of peptides of different potency 
were gifted from Dr. David Cole [127]. Originally, the reagents were used to make 
TCR:pMHC affinity measurements. Proper assay development permitted recycling of the 
experimental data for memory analysis. The memory index had no trend with ligand 
potency (Figure 11C). The values were not statistically different when compared with a 
one way ANOVA test.  
5.4 Analysis of purified TCR:pMHC systems 
(A) Memory index for recombinant OVA Altered Peptide Ligands (APLs) vs. naïve OT-
1 T cells. (B) Memory index for recombinant Hb APLs vs. naïve 3L2 T cells, Data are 
compiled for contact times of 0.1-5seconds, 50 contacts, for A&B. Error bars represent 
standard error. (C) Memory index of panel of recombinant pMHC against clonally 




The first question to be answered is whether the positive memory index in 
TCR:pMHC binding is intrinsic to the molecules themselves. Because purification of the 
extracellular regions or recombinant production is difficult for the TCR, the analyzable 
systems were limited. Dr. Baoyu Liu provided data he had collected using purified OT-1 
TCR vs. ovalbumin peptide fragment OVA. This system previously exhibited positive 
memory in its cellular context [126]. Memory index across several different contact times 
was binned to determine any significance, as only one data point can be extracted from a 
sequence of touches and the calculation itself has high variance. In future sections, it will 
be shown that the memory index has little dependence on contact time. In the purified 
system OT-1:OVA system, no memory is seen (Figure 12A). In another data set provided 
by Muaz Rushdi, E8 TCR recognizing peptide fragment TPI, the purified system did not 
express positive memory whether or not the streptavidin used for conjugation was divalent 
or tetravalent (Figure 12B). This implies that clustering of TCR does not influence this 
effect in the absence of the cellular environment. Neither result is significantly nonzero.  
 
Figure 12. Purified TCR:pMHC memory index 
 
Data are compiled for contact times of 1-10seconds for (A) Memory index for 
recombinant OVA MHC vs. recombinant OT-1. (B) Memory index for recombinant E8 
TCR vs. TPI MHC, Divalent vs. Divalent (DvsD) and Tetravalent vs Tetravalent (TvsT) 
streptavidin. Error bars represent standard deviation.  
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5.5 Mechanism exploration by dynamic input micropipette assay  
5.5.1 Dynamic input micropipette assay 
As seen in Section 5.3, the micropipette assay will not suffice to accurately measure 
ligand memory or its dynamics for several reasons. First, micropipette methods are subject 
to high variability due to the inherent stochasticity of the assay and the low number of 
events. Second, additional variability in the assay introduced through user errors such as 
1) misidentification of bonds, 2) time lapses in the process, or 3) user bias 4) pipette drift 
may lead to misidentified or neglected events which significantly impacts a time series 
measurement such as the memory index. Lastly, measurements are done with constant 
contact time over the course of a cell pair and constant time in between contacts. Because 
we began this study with the intent of studying the time-dependent memory effects, a new 
method needed to be developed to study it.  
It has been shown that using random, unbiased, inputs to a system can better help 
to understand the inherent dynamics and cell signaling [128]. In this assay, we have two 
controlled variables: the contact time and time in between contacts, or waiting time; pMHC 
density can also be controlled, but due to the sensitivity of the memory index, it is best to 
keep the adhesion frequency around 0.25-0.75 which limits the density variation. 
Combining the aforementioned issues with variable system inputs makes the process 
impossible in a practical sense. To overcome these issues, the HAFM automated this 
process to improve bond identification and record the effects of variable inputs. Otherwise, 
this assay has the same output as the micropipette assay: a series of events, where 1 denotes 
a contact period, or event, ending in a bond and 0 denotes an event with no bond.  
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In the dynamic input micropipette assay, a cell with the receptor of interest (TCR) 
is brought into contact and allowed to interact with its ligand (pMHC) on the bead surface 
through piezo control for a randomized period of time (0.25-5s) to an approximate 
maintained force level. The cell is the separated for a different randomized period of time 
(0.25-5s). Throughout this process, deflection of the cantilever is translated into a signal 
through a focused, reflected laser and measured through the photodiode (Figure 7). If a 
bond exists at the end of the contact period, it can be detected through deflection of the 
cantilever. This process is repeated several hundred times for a cell and bead pair. This 
data is then output and analyzed as a series of binding events.  
5.5.2 Effects of ligand potency on TCR ligand memory 
To study the TCR ligand memory in the context of antigen recognition, we required 
a stable TCR system with flexibility. We received a TCR-deficient J.RT3-T3.5 Jurkat cell 
line with a human HLA-A2 restricted 1E6 TCR (1E6-J). This cell line expressed constant 
TCR expression over several weeks which was necessary to negate the possible impacts of 
variable receptor expression. Additionally, a panel of pMHCs with different potency were 
provided for the 1E6 system [127].   
The dependence of TCR ligand memory on peptide potency was characterized 
using the 1E6-J system on a panel of six peptides of different potency. At high or low 
adhesion frequencies, artifacts may be induced into the calculation of the memory index 
due to lower sensitivity. Therefore, the average adhesion frequency of each ligand was 
maintained between 0.4-0.6 by varying the pMHC bead coating density (Figure 13A). 
However, there was still a significant amount of non-specific adhesion that was not 
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inherent to the TCR:pMHC interaction as showed by ~10% binding in non-coated bead 
(SA) or control peptide (CBL-A2). However, it was shown by Monte Carlo simulation that 
if the non-specific adhesion sequences are Bernoulli, the trends in memory index remain. 
However, the addition non-specific adhesion leads a sensitivity decrease. At 10% non-
specific adhesion, this would lead to an approximately 20% decrease in the calculated 
memory index (Figure 13B). 
 




As the potency of the ligands increased, the TCR ligand memory decreased 
significantly in a non-linear fashion (Figure 14A). Even with 200-300 contacts for each 
measurement which should significantly limit data spread, the high variance of the assay 
is apparent (Figure 14B). There are several possible explanations for this variation. First, 
cell-to-cell and bead-to-bead variation are a source of error. Receptor and ligand densities 
(A) Adhesion frequencies for different ligands tested vs 1E6-J cells. SA is uncoated 
beads. CBL-A2 is a control peptide. Adhesion frequencies were maintained to a mean 
of approximately 0.4-0.6 by control of pMHC coating density. (B) Monte Carlo 
simulations of micropipette adhesion sequences with inputs of the memory index and 
non-specific adhesion. Baseline adhesion frequency was maintained at 0.3. The output 




have an inherent level of variance that is extremely difficult to quantify for a single pair. 
Additionally, the randomized contact and waiting times produce additional variance in this 
parameter since not all events are based on the same conditions. However, the trend of 
ligand potency on memory index is apparent.  
 
Figure 14. TCR ligand memory dependence on peptide potency 
 
 
Despite the memory index having an interesting trend with ligand potency, the 
memory measurement reflects relative sensitivity, or sensitivity increase relative to itself. 
Sensitivity changes in binding, as described in Figure 24, are quantified by the increase in 
binding relative to the amount of ligand present. Ligands of stronger potency (YQF, RQW) 
require ~200-400 fold higher coating concentrations to reach the appropriate amount of 
binding than weaker ligands (ALW, YLG). Therefore, true ligand sensitivity as quantified 
by the memory index reverses trend when normalized by the peptide coating density 
(Figure 15). Interestingly, ALW peptide, the naturally occurring derivative of insulin 
related to some forms of type I diabetes, does not fit the trend. Its value increases to 
(A) Peptide potency, quantified as peptide concentration required to reach half maximal 
T cell killing, vs. memory index for 1E6-J cells against a panel of peptides. Error bars 
represent standard error for memory index calculation. (B) Individual data points from 
different peptides for same experiment with control of uncoated beads (n = 7-11) 
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approximately that of 10x stronger peptide RQF-A. However, it should be noted that this 
normalized value is also not necessarily a better quantification of the change in sensitivity, 
as this quantity is reflective of a Markovian probability upregulation depending only on 
the previous bond. If ligand memory last longer than simply two events, which we will 
show is the case in future sections, this metric will be skewed. More investigation will be 
required to quantify absolute sensitivity changes.    
 
Figure 15. Normalized memory index dependence on ligand potency 
 
5.5.3 Generalized linear regression model of TCR memory 
We analyzed the previous data collected in Section 5.5.2 using a generalized linear 
regression approach to examine trends with contact and waiting times. It was believed that 
given enough waiting time, this effect would decay; additionally, given enough contact 
time for binding/signaling, this trend would increase. In this method, the probability of 
adhesion was determined using GLR both after a bond, p1(ct,wt), and after no bond, 
p0(ct,wt), using covariates of contact and waiting times controlled in the experiment. The 
memory index dependency was therefore p1(ct,wt)) - p0(ct,wt)). Unexpectantly, little to no 
Memory index normalized by the coating density of MHC required for adhesion 
frequency of 0.4-0.6. Error bars represent standard deviation. Arrow denotes direction 
of increasing potency. 
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dependence was seen on either contact or waiting time for any ligand (Figure 16); some 
small changes were seen in weaker ligands, but this is most likely due to an artifact of the 
fitting process. Therefore, the memory index metric is indicative of extended periods of 
kinetic upregulation longer than the time intervals in this study. 
 
Figure 16. TCR ligand memory dependence on contact and waiting times  
 
5.5.4 Lck assists in triggering long periods of adhesion 
When considering a mechanism underlying TCR ligand memory, two aspects of 
these upregulated binding periods need to be considered. How long are these periods and 
how are they triggered? As discussed previously in Section 2.2.2, the CD3 subunits 
associated with TCR become phosphorylated by kinase Lck on the ITAMs upon TCR 
A generalized linear regression model was fit to contact times and waiting times in the 
experimental assay for all 6 ligands in Figure 14. Plots are ordered from weakest ligand 
top left to strongest ligand bottom right. 
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activation. Therefore, Lck is a crucial manipulation target for understanding if and how 
TCR triggering impacts ligand memory. To test the hypothesis that CD3 ITAM 
phosphorylation impacts TCR ligand memory, we inhibited Lck through an Lck-specific 
inhibitor which competitively binds the ATP binding site required for activity [61, 129] 
using the same system as previously described (Section 5.5.2) and the high memory ligand 
ALW. The adhesion frequency did not significantly change with the addition of addition 
of Lck inhibitor (p>0.1) although it appeared to decrease slightly (Figure 17A). However, 
Lck inhibition led to a significant decrease in memory showing the unique sensitivity of 
this measurement over standard micropipette analysis (Figure 17B). Baseline adhesion 
frequency, that is the adhesion frequency after there was no bond in a previous contact, did 
not change (Figure 17C), implying that the memory effect is indicative of upregulated 
binding periods, not downregulation of binding. The memory index was still however 
significantly above zero, which we found to be counterintuitive. Because the Lck inhibitor 
can act in a dose-dependent fashion, it was possible Lck was unsaturated and the small 
fraction of active Lck could maintain some of the memory effect. To confirm this 
behaviour, we added a much higher level of inhibitor (20M) to affirm Lck saturation. 
However, this did not change either the adhesion frequency or memory index (Figure 17).  
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Figure 17. Impact of Lck inhibition on adhesion frequency and ligand memory 
 
 
Because the memory index in these experiments was indicative of long, upregulated 
periods of adhesion (Figure 16), a nonzero level of memory upon inhibition indicated that 
Lck plays either or both of two roles in TCR ligand memory: 1) Lck assists in maintaining 
the length of upregulated adhesion periods, thereby leading to more bonds in series and a 
higher memory index, or 2) Lck assists in triggering the occurrence of upregulated binding 
periods, thus increasing the probability that these periods occur and increasing memory 
index. To examine these two roles, we employed a variety of analytical techniques to the 
data. 
To determine if the duration of the upregulated binding periods decreased upon Lck 
inhibition, we first looked at the average cluster size – that is, how many bonds occur in a 
row – and normalized this by the average cluster size expected by the adhesion frequency 
of a Bernoulli sequence. In effect, this normalization would account for the small 
differences in adhesion frequency seen previously. The normalized cluster size decreased 
(A) Adhesion frequency for Lck inhibition vs DMSO carrier for 1E6-J cells vs. ALW 
coated beads using dynamic input micropipette assay. (B) Memory index analysis for 




with the addition of Lck inhibitor (Figure 18A). Additionally, when we looked at the time 
duration of the clusters – the time from the first bond to the last bond in a sequence – there 
was no significant difference between the Lck inhibitor and control as their 95% confidence 
intervals on the mean overlap (Figure 18B-D). However, the non-parametric Dunn’s 
multiple comparison test, used because of non-normality of the data sets, indicated that the 
median values may be different between the inhibitor and control (p<0.05).  
There is one major difference which can account for the discrepancy between the 
two metrics of cluster length. The duration of a cluster (Figure 18B-D) cannot be calculated 
for clusters of one (i.e. when there is a sequence of no bond, bond, no bond) since there is 
no length to the cluster; the normalized cluster size can incorporate this data. Therefore, 
we believed that these clusters of one, or non-triggering events, may be critical to 
understanding the process. We quantified their relative frequency between the control and 
Lck inhibitor data sets. Effectively, Lck inhibition leads to a significantly increased fraction 
of non-triggering events (Figure 18E). This may also explain the contradictory statistical 
tests on the cluster duration. If low probability multiple triggering events cannot occur as 
regularly with Lck inhibition, this would lead to a slight shift in the average duration which 
may not be detectable through some statistical tests. Taken together, these data imply that 
the role of Lck in TCR ligand memory is to promote the triggering of upregulated binding 
periods and not to extend their duration. 
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5.5.5 Cholesterol binding to TCR inhibits ligand memory 
Cholesterol and lipid regulation play a significant role in many cellular behaviours 
[130]. In T cells, lipid rafts on the membrane form dense clusters home to many types of 
receptors and signalling molecules. The TCR itself primarily resides in such domains in 
resting cells [45, 54, 57]. Cholesterol is a primary regulator of TCR preclustering. Recent 
discoveries as to the binding of TCR subunit to cholesterol and its regulation of signalling 
suggested it may be another target for manipulation of TCR binding [55, 58-60].  
(A) Cluster sizes normalized by the expected value of a cluster size of a Bernoulli 
sequence of the same adhesion frequency for Lck inhibitor and DMSO carrier. Error 
bars represent standard deviation. Distributions were checked for normality and 
significance values were calculated using two-tailed student t-test. (B-D) Relative 
frequencies of cluster duration for same cases. Confidence intervals on the mean are 
noted for each panel. (E) Ratio of single bond clusters to total number of clusters. Error 
bars represent 95% confidence interval.  
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To examine the impact of cholesterol on TCR ligand memory, we first treated the 
1E6-J cells with cholesterol oxidase. Although oxidation of cholesterol leads to many 
functional changes in cells, it primarily reduces cell membrane cholesterol content and 
disperses clustering. Treatment of cells with cholesterol oxidase completely removed 
memory (Figure 19).  
 
Figure 19. Cholesterol oxidase treatment effects on TCR ligand memory 
 
A recent paper by Wang and colleagues [58] shed light on a naturally occurring 
analog of cholesterol, cholesterol sulfate, which has been shown to displace naturally 
occurring cholesterol and bind stronger to the TCR. Interestingly, cholesterol sulfate 
appeared to decrease binding of tetramer pMHC to TCR. Measurements using divalent and 
monovalent antibodies for different TCR subunits implied that cholesterol sulfate treatment 
induced dispersal of TCRs on the membrane. However, it did not rule out changes in the 
kinetics or affinity. 
To test the effects of cholesterol sulfate on memory index, we treated the 1E6-J 
cells for 1 hour with different concentrations of cholesterol sulfate and performed the 
Memory index for 1E6-J cells vs ALW pMHC with and without cholesterol oxidase 
treatment. Error bars represent standard deviation.   
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dynamic input micropipette assay against ALW in the continuous presence of cholesterol 
sulfate or vehicle DMSO. Addition of cholesterol sulfate decreased TCR ligand memory 
in a dose-dependent fashion. The slope of the fitting was significantly nonzero. 
Additionally, the baseline adhesion frequency decreased slightly with cholesterol sulfate 
treatment, implying that cholesterol sulfate addition is changing the kinetic states of the 
TCR even before priming. Analysis of the cluster duration showed that the duration of the 
clusters decreased with increasing cholesterol sulfate concentration. The trend in the 
histograms is apparent as well – as more cholesterol sulfate is added, the relative frequency 
of shorter clusters increases and the tail begins to disappear.  
 




(A) Memory index for 1E6-J cells vs ALW pMHC with cholesterol sulfate treatment or 
DMSO vehicle. Error bars represent standard deviation. (B) Correlation of memory 
index vs cholesterol sulfate dose. Error bars represent standard error. P-value represents 
likelihood of non-zero slope. (C) Base adhesion frequency for cholesterol sulfate 
treatments. Error bars represent standard error. (D-F) Duration of cluster histograms for 
each cholesterol sulfate treatment. Confidence intervals are noted on each panel  
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5.6 Modeling and simulation of TCR ligand memory 
The combination of Lck inhibitor data and cholesterol treatments imply that the 
mechanism behind TCR ligand memory is under tight control by the molecules most 
proximal to its function. Several key points concerning the mechanism must be considered. 
1) TCR ligand memory is reflective of switching between two dynamically reversible 
states of kinetically different TCRs – a low affinity binding state whose binding 
induces a higher affinity binding state. The states must be dynamically reversible or 
the trend would be towards higher and higher binding frequencies as the assay 
progresses, which is not the case – the binding appears to come in “waves”. It is 
possible that there are 3+ states, but the dynamic input micropipette assay does not 
have the refinement capable to discern between 2 or 3+ states. Therefore, we will 
consider the simplest case of a two-state TCR binding model. 
2) Cholesterol binding may be the primary regulator in modulating the two TCR states. 
A memory index of zero implies that there is only one kinetic state. The effect of 
cholesterol sulfate on memory index trends toward zero at high concentrations; due 
to the toxicity of DMSO on cells and low solubility of cholesterol sulfate, higher 
concentrations were not experimentally feasible. Removal of cholesterol from the 
membrane also induced no memory and therefore a single state.  
3) Lck regulates the ligand memory triggering likelihood. It has been shown that 
cholesterol binding to TCR sequesters phosphorylation of CD3 ITAMs. However, 
once phosphorylated, cholesterol is unable to bind to TCR according to recent 
models. As a consequence, addition of Lck inhibitor would shift the TCR population 
balance towards cholesterol binding.  
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4) Signaling for conversion of the two states and regulation of cholesterol binding must 
be controlled by a mechanism which has not been exclusively identified in this 
study.  
Combining literature and the data presented in this study implies a model of TCR 
ligand memory where 1) TCR binds pMHC, 2) the TCR:pMHC complex undergoes a 
modification that induces signaling, and 3) this signaling releases cholesterol from nearby 
TCRs. Therefore, we simulated this mechanism in its simplest case to see whether or not 
it could replicate the memory effect. 
The mechanism for simulation is outlined in Figure 21. It has been suggested recently 
that TCR clusters should be considered as their own signaling units; the data collected from 
the cholesterol sulfate treatment also suggests this may be the case. Therefore, the 
mechanism is outlined as such. At resting state, TCRs in a cluster are considered to be 
inactive and have at on and off rate for pMHC, kr and kf, which are unique to the resting 
state. Once TCR and pMHC bind, signaling is induced and the cluster of TCRs undergoes 
one-step kinetic proofreading described by the parameter kc. If unsuccessful, nothing 
happens and the TCR unbinds from MHC. If successful, the cluster of TCRs switches states 
to an upregulated xTCR state, governed by two new kinetic rates, kf,x and kr,x, which are 
unique to the upregulated state. The cluster of TCRs will then revert back to resting state 




Figure 21. Simulation mechanism outline 
Despite the large amount of data collected measuring the presence of bonds at certain 
periods of time, parameters in this model cannot be directly derived from the acquired data. 
To estimate the kinetic parameters governing this mechanism, we simulated micropipette 
sequences using a custom designed algorithm. Each individual TCR cluster across the 
interface between a cell and bead was simulated for a random contact period in the range 
of the experiment. TCR clusters were permitted to diffuse for random MHC encounters. 
The surfaces were then separated. If a bond or bonds were present at the end of contact for 
any of the TCR clusters, they were broken and a bond event is recorded. A randomized 
period of waiting time was then applied to replicate experimental conditions. The stochastic 
simulation algorithm with no approximations was used to solve the equations [131, 132] 
which relies on the inherent chemical kinetics of the molecules (on/off rate) and 
characteristic areas of interaction. Parameters used in the simulations are presented in Table 
3.   
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Table 3. Simulation parameters for mechanism investigation 
 
Because there are six unknown parameters and an individual run takes approximately 
10 minutes for a ~40 cell pairs, standard methods of parameter estimation would take a 
significant amount of time. We therefore employed a statistical technique developed by 
colleague Dr. Chih-Li Sung and colleagues. In this technique, experimental data is fit to a 
statistical model similar to a logistic regression with the addition of a Gaussian noise term. 
Monte Carlo scanning of the simulation parameter space using a logarithmic Latin 
hypercube approach created data sets of simulated data for analysis by the same statistical 
approach. Error between the two analyses, experimental and Monte Carlo simulations, is 
minimized converge on approximate values of the unknown parameters. This results in 
significantly faster convergence. 
Simulations were solved through a Stochastic Simulation Algorithm (SSA) approach 
[131, 132] in MathWorks Matlab (R2015b) using customized algorithms (Figure 22). Each 
cluster of TCRs was modeled as its own signaling and binding unit, so the number of TCRs, 
pMHC, and clusters required random selection. In the initialization module, the number of 
clusters in the interface was determined by dividing the average TCR density on the surface 
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by the average number of TCRs in a cluster. For each cluster, the number of TCRs within 
that cluster was derived from a uniform distribution on the specified interval. The initial 
number of pMHC in each cluster was determined by knowing the average pMHC density. 
From the cluster area, the average number of pMHC in this area can be calculated. The 
number of pMHC in the cluster was then randomly selected from the Poisson distribution 
with the previously calculated average. All other known parameters were initialized.  
Unknown parameters were segmented logarithmically along the specified interval by 
the number of required logarithmic Latin hypercube divisions. These segmented vectors 
were randomized. The maximum and minimum possible parameter values were estimated 
from biophysical approximations and adjusted so as to not limit the parameter space 
resulting in false convergence. The segmented vectors were then randomized, and the 
simulations iterated through these vectors to solve for the binding sequence. Relevant 
parameters are outlined in Table 4. 
Table 4. TCR ligand memory mechanism simulation parameters 
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After initialization, each individual cluster’s binding was simulated over the contact 
period randomly selected from the interval 0.25-5s. Once each cluster was simulated, if 
any of the clusters remained bound after the contact period was completed, the event was 
marked as a bond and those bonds were broken. If no bonds were present in any of the 
clusters after that time, no bond was recorded. A waiting time was randomly selected from 
the uniform interval 1-6s to reflect experimental conditions. This cycle was repeated until 
the simulation reached the input number of contacts. For calibration of parameter values, 
20 cell pairs with 300 contacts were simulated for each set of parameters with a 120-sided 
hypercube. 
 
Figure 22. Micropipette simulation algorithm outline 
The results of the fitting are seen in (Table 5). Because there may be many different 
minima in the fitting space and the statistical fitting method may result in artifacts, it is 
important to consider many different local minima; in this case, we decided to look at the 
20 best fitting parameter sets as determined by their statistical cost function, L2 distance.  
Upon initial inspection, some of the parameters reached the maximum or minimum of their 
 65 
simulation intervals. This is not an ideal case, but it still may be an appropriate fit. This 
required testing. 
Table 5. Twenty best parameter fits by statistical model 
 
Therefore, we performed simulated micropipette assays in the same fashion, but 
provided the fitted parameters as inputs. The results indicated that there were several 
artifacts induced by the statistical fitting method (Figure 23). Several parameter sets had 








Therefore, we eliminated these obvious outliers from the parameter fittings. The 
majority of these outliers were the same parameter sets which contained a parameter that 
hit the maximum or minimum of the simulated interval. Interestingly, when these outliers 
were removed, some significant and consistent trends began appeared (Table 6). The 
upregulated binding periods appear and disappear quickly, as seen by the magnitudes of kc 
and kd, respectively. The on-rate for the upregulated state increased several hundred fold, 
and the off-rate increased 10-20 fold. These interesting parameter trends indicate that the 
TCR, upon recognizing antigen, very quickly upregulates the kinetics of nearby TCR to 
rebind antigen. It releases that antigen soon after for rebinding to another TCR, which again 
quickly dissociates, allowing another TCR to rebinding. This mechanism would permit 
several TCRs to interact with the same antigen in quick succession.  
Statistically-fitted parameter sets were used to simulate the micropipette assay using 20 
cell pairs, 300 contacts. Their memory index and adhesion frequency were calculated 
from the simulated adhesion sequence (black circles). This is compared to the 
experimental data shown by the red circle. Error bars represent standard error for the 
adhesion frequency and 95% CI for the memory index. Blue ovals indicate outliers.    
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Table 6. Best parameter fits by statistical model with outliers removed 
 
5.7 Discussion and future studies 
Utilizing a panel of different peptides for a specific TCR and a series of 
pharmacologic interventions, we show that adhesion memory is the result of a complex 
process regulated through TCR proximal interactions. Unexpectedly, weaker ligands 
exhibit higher adhesion memory than stronger ligands for the 1E6-J system. However, 
analyses of TCR ex vivo systems (Figure 11) did not share the same trend, suggesting that 
this mechanism may be under complex controls and tuned at the thymocyte selection level. 
Blocking of TCR-proximal signaling molecule Lck slightly decreases the duration of these 
periods, but significantly impacts the probability of their formation, suggesting a complex 
role for Lck in this process. Depletion of membrane cholesterol through cholesterol oxidase 
treatment completely eliminated adhesion memory. Addition of cholesterol sulfate, a 
naturally occurring analog of cholesterol which disrupts multimer formation and inhibits 
signaling by binding to the TCR, was shown to deplete adhesion memory in a dose-
dependent fashion.  
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Simulations of this mechanism revealed that the TCR upregulates its binding affinity 
10-20 fold to pMHC ALW. This increase is attributed to the interplay between the kinetic 
on-rate and off-rate – approximately several hundred fold and 10-20 fold, respectively – 
both of which are important regarding the mechanism influence on antigen recognition. 
This reflects a very dynamic process. Once a TCR recognizes antigenic pMHC, it 
communicates to nearby TCRs that an antigen is nearby by the same signaling molecules 
as the triggering process. That pMHC dissociates, and it remains in the vicinity of TCRs 
which are primed to quickly recapture it and release it. By this mechanism, several TCR 
engagements with antigen occur very quickly, fostering more triggered TCRs each binding 
event. It is a signal amplification mechanism derived from its effects on ligand binding 
sensitivity. Although not simulated this way, it is likely this signal may spread between 
TCR clusters, similar to ZAP-70 catch-and-release observations where a signal originates 
from a single TCR cluster and transitions out to perform its function [133]. Therefore, even 
a signal antigenic pMHC could induce T cell activation. Despite experimental evidence for 
TCR kinetic binding upregulation [46-48], this is the first evidence regarding a mechanism 
which could give rise to this behavior.  
However, we must consider that this is not the only possible interaction network; it 
is quite possible that memory may be induced by other mechanisms which may have 
different implications. This should not be considered the only possible interpretation of our 
data. The model we chose was based largely on the pharmacological inhibitions used in 
experiments and previous knowledge from the literature. We are currently working on 
developing statistical metrics to compare the validity of different mechanistic models. 
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Future publications examining the merit of these different possibilities will be critical to 
interpreting the data. 
These upregulated periods of adhesion probability in the micropipette adhesion 
frequency assay are indicative of changes in the inherent kinetics of the interaction. These 
changes are unlikely to occur at the single TCR level because the on-rate increase would 
be outside conceivable ranges. Similarly, a whole cell binding upregulation would require 
an extremely fast switch-like response and would not be resource efficient considering the 
cell only has knowledge of the existence of a single antigen. However, if the TCR is able 
to upregulate its binding kinetics and the kinetics of nearby TCRs in response to previous 
binding, this process would help to recapture the same antigenic pMHC. As a result, TCR 
binding induces more TCR binding, leading to further stimulation of the cell. This 
mechanism is similar to rebinding models [82, 87] where a signal can persist after bond 
dissociation to propagate signaling and increase antigen sensitivity.  
We propose that this positive memory index acts as a measure of ligand sensitivity 
similar to the Hill coefficient in enzyme kinetics, but with an effect in time rather than 
concentration, and represents an inherent self-regulation to ligand binding. Hill kinetics 
moderates reaction velocity in a substrate concentration manner (Figure 24A, top panel), 
thereby increasing the sensitivity to ligand. This results in a heightened sensitivity window 
for positive cooperative ligands over traditional kinetics. Similarly, ligand memory shows 
increased bond formation in time (Figure 24B, top panel). This leads to a heightened 
sensitivity to ligand in time, followed by a desensitization back to steady-state (Figure 24B, 
bottom panel). This results in much more dynamic responses to ligands over what was 
previously considered.  
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How does this behavior result from the physical properties of the TCR? At this point, 
the obvious scapegoat is conformational change to the TCR prompting a more amenable 
binding interface. A conformational change to TCR or its CD3 subunits has been postulated 
by several groups [90, 134-137], but it has not been shown to directly affect pMHC 
interaction kinetics. There is some evidence for this in the survival distributions of lifetime 
under force which occasionally show multiple dissociation rates, but there is very little 
supporting structural evidence. In another interpretation, the binding of cholesterol to TCR 
provides an allosteric effect limiting the range of motion of the distal pMHC binding site. 
This would directly constrain the effective kinetic on-rate for the interaction. Cholesterol-
induced allosteric effects have been known to impact TCR triggering [59], but its effects 
(A) Hill Kinetics reaction velocity (top panel) or sensitivity (bottom panel) vs substrate 
concentration for cases of no cooperativity, negative cooperativity, and positive 
cooperativity (black, red, and green curves, respectively). (B) Ligand memory average 
bonds (top panel) or binding sensitivity (bottom panel) vs. time for cases of no memory, 
negative memory, and positive memory (black, red, and green curves, respectively) 
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on kinetics are unknown. Determining a direct mechanism at the TCR level is an exciting 
potential direction for future research.   
There are many different implications of this study for further research. This 
enhancement would be intriguing in an in vivo context where many different antigenic 
pMHC are present alongside weaker or self pMHC. For instance, a triggering event may 
occur for upregulated binding, but that pMHC escapes recapture. However, the cluster of 
TCRs encounters other, weaker antigens and continues signal persistence for T cell 
activation. Additionally, the process could occur in the opposite fashion – weaker ligand 
activation of TCR upregulated binding for strong agonist capture. The complex interplay 
between ligands of different potency is not studied here, but future studies could examine 
the impacts of concepts such as antagonism [138] or co-agonism [139], phenotypic 
explanations for the complex interplay between peptides of different potency, on TCR 
ligand memory. Models have suggested that this behavior is the result of signaling 
networks [140, 141], but there is a strong evidence presented in this study that the quality 
of the peptide impacts the binding of the TCRs. 
This new mechanism has implications at many levels of the T cell activation process. 
We have shown that TCR ligand memory can be tuned by extracellular factors, such as 
cholesterol sulfate. Likely, this binding enhancement is regulated through a combination 
of soluble factors, such as hormones and cytokines, impacting membrane cholesterol 
content and proximal signaling molecule activity prior to APC contact. It has been shown 
that T cell lineages have differential TCR clustering [142] and Lck activity [112]. Co-
stimulatory (CD28) or co-inhibitory (PD-1, CTLA-4) pathways intercede with TCR 
signaling pathways, adding a layer of regulation once cells have come in contact.  
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Additionally, although the mechanism presented here is a good candidate for memory 
induction, it is not the only possible network. Model selection is often a difficult task, and 
the finest details may be of unique importance. Small modifications to this mechanism, 
such as adding aspects of force due to pulling of the bond at the end of contact or inducing 
ligand dissociation upon a state conversion, are critical points to the mechanism which 
require further investigation. We are currently in the process of developing unique 
statistical methods to compare the validity of other mechanisms for optimal model section.  
Sensitivity changes are typically assayed at the level of T cell activation on a 
population level, such as increased cytokine secretion or targeted cell killing. However, 
these metrics are far removed from how the TCR itself produces this behavior in very few 
binding events. Models have attempted to rectify the unique TCR binding sensitivity and 
specificity, but are susceptible to undesirable activation [51, 79, 83, 85, 87]. By using a 
new methodology with a unique metric of sensitivity, we showed that TCR regulates its 
own binding capacity, and this regulation is under the control of the molecules most 
proximal to its own triggering. This new mechanism provides a foundation for discoveries 







CHAPTER 6. ROLE OF MECHANICAL FORCE IN CD8 
CORECEPTOR BINDING AND ITS IMPACT ON T CELL 
TOLERANCE 
6.1 Introduction 
The role of coreceptors in TCR antigen recognition has been debated since their 
influence on T cell signaling was discovered. As discussed in Section 2.3.5, coreceptors 
CD4 and CD8 contain an intracellular motif which can bind to TCR-proximal signaling 
molecule Lck; additionally, coreceptors have a low affinity extracellular interaction with 
MHC molecules. Therefore, it is believed that the role of coreceptors is to provide a means 
for Lck delivery near sights of TCR:pMHC interactions to promote phosphorylation of 
ITAMs and subsequent TCR activation. Logically, this process seems reasonable and has 
become a cornerstone of coreceptor influence on T cell immunology. Empirically, there is 
little evidence to refute it, and this study does not intend to do so.  
However, the process of Lck delivery is not exclusive to other mechanisms in the 
TCR triggering process. In naïve T cells, several mechanisms have been explored as to the 
role of coreceptors in TCR dynamics [102, 107, 110]. Due to the presence both intracellular 
and extracellular binding interactions with the TCR(CD3):pMHC complex, coreceptors 
have been thought to stabilize the TCR:pMHC interaction by “trapping” the molecules in 
close proximity through this two-pronged binding modality [102]. For example, if the 
coreceptor unbinds from the complex (TCR:MHC:coreceptor:Lck:CD3, referred to in the 
future as Pseudo-dimer of dimers or PDD) at its extracellular region, the intracellular 
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region is still bound at the Lck:CD3 interface. Therefore, rapid rebinding to MHC occurs 
because the coreceptor is “locked” in place in a beneficial orientation by its intracellular 
binding. Similarly, if TCR unbinds from MHC, trapping of the MHC by coreceptor 
extracellular domains and the TCR by its interaction through Lck:CD3 maintains their 
close proximity, permitting rapid rebinding. In essence, this can significantly extend the 
lifetime of a TCR interaction with antigen, permitting more time for proofreading of the 
peptide for TCR triggering. This mechanism was simulated in a simple case and found to 
be insignificant [110]. However, the results were highly dependent on assumed kinetics, 
and combined with a lack of experimental evidence, the argument was not strong.   
Thymocyte selection was discussed briefly in Section 2.1.1. While in the thymus, 
thymocytes are presented with “self” ligands to develop two important facets of T cell 
behavior – tonic signaling and tolerance to self-peptides. Thymocytes which do not respond 
to self-ligand die by neglect become apoptotic. Thymocytes with TCRs which respond too 
much to self are also deleted by apoptosis [143]. In effect, this creates a pool of T cells in 
the periphery which have a specific window of strength to self-pMHC, in which they 
respond to weaker peptides, but do not elicit a phenotypical response of naïve T cells. This 
prevents autoimmune disease to self while still maintaining a pool of TCRs which have the 
chance to recognize foreign pMHC.  
The role of coreceptors in the thymocyte selection process has been considered on 
several occasions [15, 107, 111], but there is no consensus on their role and mechanism. It 
is likely that mechanisms at the thymocyte level persist into the naïve T cell population. In 
this study, we will use simulation-based analysis on force-induced bond lifetime data from 
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an OT-1 thymocyte system to parse mechanisms of CD8’s role in binding and thymocyte 
selection.    
6.2 Experimental data 
Dr. Jin-sung Hong and Dr. Chenghao Ge initiated a project to understand the role of 
coreceptors in thymocyte selection. First, they examined the role of coreceptor CD8 in the 
affinity regulation of a panel of peptides of various potency for OT-1 thymocytes, but saw 
relatively no difference along the selection region. However, the addition of force with a 
Biomembrane Force Probe (BFP) created an interesting phenomenon along the selection 
threshold; this behavior was dependent on CD8. In these BFP experiments, an OT-1 
thymocyte was brought into contact with a bead coated in the noted ligand. The bead itself 
as also adhered to a red blood cell which is used as a force transducer. The bead and 
thymocyte are then separated, and if a bond is present at the end of contact, the bond is 
stretched to a predefined force level and held at that force until dissociation. The lifetimes 
of bonds from several bonds are pooled into a lifetime vs. force curve.  
An interesting trend appeared upon analysis. Positively selecting ligands formed slip-
bonds with the addition of force, where the average lifetime of a bond decreases 
exponentially with linearly increasing force (Figure 25E-G, blue labels). Negatively 
selecting ligands, those which induced apoptosis due to strong signaling, formed a catch-
bond which has the counterintuitive response of increasing lifetime with increased force 
and was followed by slip-bond behavior (Figure 25A-C, red labels). This enhancement 
relied on the cooperativity of CD8, as antibody blocking of the CD8:MHC interaction or 




Figure 25. Positively selecting ligands form catch-bonds while negatively selecting 




 They next tested another transgenic mouse system that utilized the OT-1 TCR with 
a modification to CD8 which gave it a CD4 tail which has a higher affinity for Lck (named 
CD8.4). It was known that this mouse system shifted the threshold for selection slightly, 
making Q4H7, a previously positively selecting ligand, into a negatively selecting ligand. 
This modification also turned the slip bond from the Q4H7 to a catch bond (Figure 26C). 
Additionally, the CD8.4 mutation made negatively selecting ligand Q4R7 into a much 
stronger catch bond (Figure 26D). Interestingly, these catch bonds could be eliminated 
Bond lifetime vs. applied force for OT-1 thymocytes vs. a panel of different ligands. 
Green squares are wild-type pMHC, allowing both CD8 and TCR binding, black 
triangles for CD8 only, and gold circles for TCR:pMHC binding only. pMHC are noted 
on the top of the panel, negatively selecting ligands in red, positively selecting ligands 
in blue. T4 represents a special case in the middle. Error bars represent standard error. 
Data adapted from submitted manuscript with permission from Dr. Jin-sung Hong. 
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through the addition of an inhibitor for the Lck kinase activity (Figure 26A-D) with the 
exception of Q4R7 in the CD8.4 system although this data has low confidence. 
Furthermore, Previous co-immunoprecipitation (co-IP) studies showed that TCR-CD8 or 
CD4 conjugation through Lck requires ITAM phosphorylation for recruitment of ZAP-70 
as an adaptor for Lck intracellular binding to CD3 [144, 145]. In another similar BFP assay 
where the tyrosines of the CD3 ITAMs were mutated to inactive phenylalanines, there 
was a slight reduction in the catch bond; other ITAMs from non-CD3 subunits likely 
subdued a complete catch-bond elimination. Therefore, Lck phosphorylation of the CD3 
tails plays a role in this catch-bond behavior. Overall, this data suggests that the catch-bond 
criteria is consistent even after shifting the selection threshold by intracellular 
modifications; additionally, the kinase activity of Lck is critical for this behavior, likely by 
phosphorylation of CD3 subunits. 
 




Bond lifetime vs. applied force for OT-1 thymocytes vs. Q4H7 (blue) or Q4R7 (red) for 
wild-type CD8 or CD8.4 thymocytes. Black open squares: DMSO control, solid green 
squares: addition of Lck inhibitor, gold circles: TCR-pMHC only binding with the 
addition of Lck inhibitor, solid black triangles: CD8 binding only with the addition of 
Lck inhibitor, open gold circles: TCR-pMHC binding only, no DMSO. Error bars 
represent standard error. Data adapted from submitted manuscript with permission from 
Dr. Jin-sung Hong. 
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Combining these data sets gives a unique subjective criteria of negative selection – 
that is, negatively selecting ligands form a catch bond with TCR in the presence of CD8. 
However, this is not a quantitative metric for selection and the impacts are difficult to 
comprehend. Several questions arise from this data. What does the catch bond mean in this 
context? How does increasing conjugation of Lck to CD8, an intracellular interaction, 
modify the extracellular binding kinetics? And lastly, how does this behavior result in 
thymocyte selection? In the next few chapters, we will undergo simulation-based analysis 
on these data sets to explore these questions and suggest a mechanism behind such complex 
responses. 
6.3 Long-lived bond formation is a diffusion limited process 
6.3.1 Survival distributions indicate multiple bond states 
The measurements presented in lifetime vs. force curves (Figure 25, Figure 26) is 
very difficult to understand in its current binned form; information is lost in the binning 
process which can assist in understanding the cause of the behavior. Therefore, it is critical 
to begin investigation at the data within the bins themselves, each containing many 
lifetimes acquired at the given force level. The data within an individual bin is classically 
presented as a survival distribution – the probability of a bond surviving vs. time. A 
survival distribution for a bond at a given force is an exponential decay function [146], and 
when plotted on a semi-log axes, should result in a line with slope equivalent to the 
resulting off-rate for the molecular interaction (Figure 27A). The average bond lifetime can 
then be found by integrating this curve. 
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There are unique two possibilities for changes in the survival curve which result in 
catch-bond behavior. First, the survival distribution may decrease in slope, therefore 
decreasing the molecular off-rate and increasing bond lifetime (Figure 27B). This is 
indicative of a single-bond state which is induced by force. Essentially, all bonds respond 
to force similarly when pulled, and all bonds increase bond lifetime. Secondly, the survival 
distribution may change to have two or more slopes (Figure 27C). If one of the slopes is 
small and the population large enough, this results in a small subset of the bonds with long 
lifetimes which dominate the average bond lifetime. Interpretation of this data can be very 
difficult, especially in the context of the cellular environment where signaling and 
membrane dynamics are prevalent. The response of the OT-1 thymocytes in Figure 25 is 
the second case. There is a new, long-lived bond state induced by force with a ~50x slower 
off rate than the TCR:pMHC interaction alone (Figure 27D).  
 
Figure 27. Catch bonds arise from two possible survival distributions 
 
(A) Example survival distribution at zero force contain a single bond state. (B) The 
application of force may induce a new bond state. The off-rate becomes smaller for all 
bonds, and the average bond lifetime increases. (C) Application of force may result in 
formation of multiple bond states, with a population of long-lived bonds (small slope) 
dominating the average. Arrow points in direction from expected to observed (B,C). (D) 
Example survival distribution for Q4R7 vs. OT-1 CD8.4 thymocytes, 12pN bin. 
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Assuming that the long-lived bonds are those which form the full 
TCR:MHC:CD8:Lck:CD3 complex, or a Pseudo-dimer of dimers (PDD), there are two 
possible explanations for this behavior. First, there is the possibility of force-induced 
recruitment. In this mechanism, pulling of one bond species, either TCR:pMHC or 
CD8:MHC, exposes a binding site in either species which enables binding. For instance, 
pulling TCR leads to release of CD3 intracellular tails for Lck binding. Secondly, there is 
the possibility of species deviations. Because the BFP experiment is performed on a single 
cell for many contacts in a row, there is the possibility that the bonds species change over 
time due to signaling or membrane perturbations. These two mechanisms will be 
investigated in the following sections. 
6.3.2 Force-induced recruitment models cannot explain data 
The concept of force-induced recruitment is outlined in Figure 28. A TCR or CD8 
is pulled through the BFP assay. If the second molecule does not diffuse into close 
proximity with the bond within the recruitment time, the bond breaks and a short lifetime 
is recorded. However, if the second molecule is recruited, the bond lifetime is extended 
due to PDD formation. As a consequence, this is primarily a passive, diffusion-based 
mechanism similar to those previously proposed. Therefore, we simulated both TCR and 
CD8 pulling to examine whether the second molecule recruitment could explain the data. 
 81 
 
Figure 28. Force-induced recruitment mechanism 
If the mechanism is genuine, the experimental fraction of long-lived bonds from 
the survival distribution should match the simulated fraction. We used a double-
exponential fit to determine the fraction of PDD bonds from the experimental data in the 
10-15pN range (catch-bond peak) for all pMHC tests except for OVA, since it is a special 
case. Although there is likely a mixture of TCR/CD8 bonds in the short-lived states, these 
are similar in off-rate and therefore can be grouped into one parameter. A triple exponential 
fit resulted in over-fitting of the data. As seen in Figure 29, the off-rate of the PDD bonds 
is not a perfect fit. Some over-fitting of the data occurs at the short-lived lifetimes to 
compensate for the time resolution of the BFP assay. However, this is not essential in 
determining the bond fraction. The double exponential fit adequately predicts the “kink” 
in the curve of the survival distribution where the dominance of the PDD fraction begins. 
This “kink” occurs at the fraction of PDD bonds. 
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Figure 29. Double exponential fit adequately predicts fraction of PDD bonds 
 
6.3.2.1 TCR:pMHC force-induced recruitment of CD8 is unlikely 
The first case considers if TCR pulling induces recruitment of CD8 bound to Lck. 
A Markov chain was used to determine the probability of CD8:Lck recruitment over a 
period of time similar to the approach presented in [111]. Additionally, the probability of 
a TCR:pMHC bond survival was determined over that same time interval using a Bell 
model approximation and the experimentally measured TCR:pMHC lifetimes. Plotting the 
two probabilities against each other and integrating yields the probability of CD8:Lck 
recruitment before bond dissociation (Figure 30A). As the fraction of CD8:Lck conjugation 
increased, the probability of CD8:Lck recruitment before dissociation asymptotically 
approached a value between 0.7-0.9 depending on the TCR:pMHC binding properties 
(Figure 30B). For reference, the fraction of CD8:Lck has been measured to be ~1.1% and 
5.8% in wild-type or CD8.4 OT-1 thymocytes, respectively, [111] but those values have 
been considered low due to assay limitations.  
Double exponential decay nonlinear least square fitting using Matlab fit function plotted 
against survival distribution of wild-type OT-1 thymocytes against Q4R7. Data is binned 
from the 10-15 pN range. 
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To bring the experimental and simulation data together, we must consider that there 
are both CD8:MHC and TCR:pMHC bonds pulled after any contact. Assuming the contact 
time of 0.1 seconds used in BFP assays, the fraction of TCR:pMHC bonds can be derived 
from the 2D kinetics of the two molecular interactions (CD8:MHC, TCR:pMHC) and the 
respective densities of the molecules, which were all measured experimentally. Comparing 
these two conditions, the probability of pulling a TCR:pMHC bond for most ligands is <0.1 
(Figure 30C). Assuming once CD8:Lck is recruited a PDD is formed near-instantaneously, 
the resultant fraction of PDD bonds is the probability of pulling a TCR bond times the 
probability of CD8:Lck recruitment before dissociation. If the model fits the data, there 
should be a 1:1 correlation between the predicted fraction of PDD bonds and the 
experimental fraction as determined by the double exponential decay fitting. Assuming 
maximum favorable conditions of 100% CD8:Lck conjugation and fast diffusion kinetics, 
the experimentally measured fraction of PDD bonds for some ligands remains significantly 
higher than the predicted fraction (Figure 30D). Despite favorable assumptions, the model 
cannot explain the experimental data. It is therefore unlikely that pulling of a TCR:pMHC 
bond can lead to recruitment of CD8:Lck and formation of a long-lived PDD bond.  
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6.3.2.2 CD8:MHC force-induced recruitment of TCR is unlikely 
The next mechanism to consider was CD8:MHC force-induced TCR recruitment 
and subsequent PDD bond formation. As example physical mechanism behind this model, 
once the CD8:MHC bond is pulled, the binding site for Lck is put in a favorable position, 
Lck is recruited, and TCR can diffuse to the bond site and bind.  In a similar fashion to 
(A) Markov chain prediction of the probability of CD8:Lck recruitment to a pulled 
TCR:pMHC bond vs. the probability of a TCR:pMHC bond survival. The area under 
the curve is the probability of CD8 recruitment before the bond breaks. (B) Markov 
chain prediction of the probability of CD8:Lck recruitment against the fraction of 
CD8:Lck present on the thymocyte surface (C) Predicted fraction of TCR:pMHC bonds 
for the BFP assay based on TCR:pMHC kinetics (1-fraction of TCR:pMHC bonds is the 
fraction of CD8:MHC bonds). The different OT-1 ligands are indicated. (D) Fraction of 
long-lived bonds determined experimentally against the predicted fraction of PDD 
assuming 100% CD8:Lck conjugation, near-instantaneous PDD bond formation after 
CD8:Lck recruitment, and fast diffusion kinetics. Error bars represented 95% confidence 
interval on the mean. Arrow indicates a region where mechanism is unlikely. 
Experimental data on the opposite side would imply some assumptions may be too 
favorable, but the mechanism still possible.   
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Section 6.3.2.1, the probability of TCR recruitment vs. CD8:MHC bond survival was used 
to calculate the probability of TCR recruitment before bond dissociation for different 
fractions of CD8:Lck conjugation (Figure 31A,B). Using maximum favorable 
assumptions, the experimental fraction of long-lived bonds was plotted against the 
predicted fraction by the Markov chain.  Again, this mechanism did not correlate with the 
data in any fashion (Figure 31C). In fact, the mechanism would result in little to no 
difference between the ligands. 
 





(A) Markov chain prediction of the probability of TCR recruitment to a pulled 
CD8(Lck):MHC bond vs. the probability of a CD8:MHC bond survival. The area under 
the curve is the probability of CD8 recruitment before the bond breaks. (B) Markov 
chain prediction of the probability of TCR recruitment against the fraction of CD8:Lck 
present on the thymocyte surface. (C) Fraction of long-lived bonds determined 
experimentally against the predicted fraction of PDD assuming 100% CD8:Lck 
conjugation, near-instantaneous PDD bond formation after CD8:Lck recruitment, and 
fast diffusion kinetics. Error bars represented 95% confidence interval on the mean. 
Arrow indicates a region where mechanism is unlikely. Experimental data on the 
opposite side of this line would imply some assumptions may be too favorable, but the 
mechanism still possible.   
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Taken together, these simulation-based analyses converge on several points. The 
simulations assume that the pulling of one bond leads to recruitment of a second molecule 
by diffusion. The fast assumed diffusion constant significantly under predicts the formation 
PDD bonds despite favorable assumptions. Therefore, the formation of PDD bonds is a 
diffusion-limited process. Additionally, there appears to be little correlation between the 
experimentally measured fraction of PDD bonds and peptide strength. Therefore, a more 
complex behavior must be occurring.   
6.3.3 Force-induced PDD formation promotes catch-bond response    
The different bond types, or species, may deviate from predicted due to a cellular 
response over time. Because the TCR and CD8 are present in the context of the cellular 
environment and the BFP assay “tickles” the cell with ligand many times in a row, there is 
a strong likelihood that signaling and modifications occur to reduce diffusion limitations 
or promote PDD formation in another manner. Effectively, the molecular environment 
changes over time, and the sequence violates the i.i.d. assumption used in Section 6.3.2. 
These environmental changes, provoked by the application of force, result in a survival 
distribution with many different species (TCR:pMHC, CD8:MHC, etc.) that are not seen 
in the absence of force (Figure 34).  
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Figure 32. Transient species deviations under force 
To understand these changes with the application of force, we examined the 
changes in PDD fraction with force using a Markov chain survival distribution algorithm 
which predicts the resulting survival distribution from an input initial species vector (the 
fraction of the bonds beginning in each state). As a result, there is no time dependency in 
this analysis. The Markov chain assumes the bond begins a combination of five different 
species (Figure 33, blue highlighted sections) and can transition between the states based 
on kinetic constants of the interactions, diffusion, and molecular densities. Bonds with 
more than one transmembrane interaction (green-filled ovals), such as TCR:CD8:MHC 
bonds, could not spontaneously unbind and required transition to a single bond state for 
dissociation. As discussed previously in Section 6.1, rebinding occurs very quickly in the 
PDD complex (Figure 33, noted by the purple oval). This on-rate increase was calibrated 
to be approximately ~1500x.  
 88 
 





The fraction of PDD bonds is unknown. Therefore, we simulated the survival 
distribution using the Markov chain approach for each bin in the force-lifetime curves to 
fit the fraction of PDD bonds (for example, see Figure 34A). The remainder of the bonds 
were determined by the 2D kinetics of the interactions and their respective densities. To 
solve the Markov chain, this initial vector of probabilities was solved in time through a 
system of ordinary differential equations which act at the probabilistic level. The kinetics 
of probability changes are governed by the chemical master equation, and therefore relate 
to easily to the inherent “solution” parameters by normalization coefficients such as area 
Markov chain connection diagram. Bubbles represent species at any given time – red 
bubbles indicate species that can break, green bubbles indicate species that are 
unbreakable and require two steps of dissociation. A (+/- molecule) notation represents 
that the interaction is close, but not currently bound. Bonds begin in any of 5 different 
states according to interaction kinetics or fit to survival distribution marked in the blue 




and concentration. The fraction of PDD bonds correlated very well with catch-bond 
behavior (Figure 34B-I). Because there is significant noise due to the stochasticity of the 
assay (discussed in future sections), combining the data sets into positively or negatively 
selecting ligand groups revealed interesting trends. The PDD fraction of slip bond ligands 
showed a relatively mild response to force (Figure 34J). Interestingly, ligands with catch-
bonds showed a more dynamic response (Figure 34K); CD8.4 responses were more 
pronounced and stronger (Figure 34L).  
 




6.4 Model and simulations on proposed mechanism explain experimental data 
(A) Markov chain fitting of 12pN bin of Q4H7 vs. CD8.4 OT-1 thymocytes. (B-I) Markov 
chain prediction of fraction of PDD bonds vs. force for wild-type OT-1 thymocytes 
against negatively-selecting ligands (B-D), positively-selecting ligands (E-G), and CD8.4 
OT-1 thymocytes against negatively selecting ligands (H,I). (J-L) Combined Markov 
chain fitting data for all positively selecting ligands (J), negatively selecting ligands (K), 
and CD8.4 thymocytes vs. negatively selecting ligands (L). Fit with a Gamma distribution 
to show apparent trend (blue line). 
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6.4.1 Proposed mechanism for catch-bond behaviour in thymocyte selection 
Previous analyses suggest that force provokes PDD bond formation; it is not a 
passive response governed through diffusive processes. For several reasons outlined below, 
we believe that TCR and CD8 may form complexes, one or more CD8s conjugating to a 
single TCR, on the surface of T cells over time. For the sake of simulation and conceptual 
simplicity, we will refer to this complex as a heterodimer or dimer. This heterodimer is the 
result of TCR mechanotransduction.  
1) The application of mechanical force on TCR triggers signaling [88, 90-93].  
2) TCR is especially responsive when pulled to a force of approximately 10pN [92]. 
Interestingly, this coincides with the PDD fraction peak (Figure 34J-L).  
3) Lck is a proximal signaling kinase in TCR signaling [61]. Lck inhibitor blocked 
catch-bond formation in negatively-selecting ligands.  
4) Coreceptors are initially separated from TCR islands which converge with TCRs 
upon TCR stimulation [109, 147]. This separation changes as T cells mature to 
increase sensitivity [148]. This effect would decrease the diffusion limitations 
outlined in Section 6.3 over time.  
5) CD8 showed increased FRET signaling with CD3 upon APC stimulation [109], 
suggesting that CD8 and CD3(TCR) come in close contact after T cell stimulation. 
Additionally, CD3 antibody stimulation indicated stimulation-induced association 
of CD8/CD4 coreceptors to TCR by co-IP [144, 145].   
Therefore, we suggest the following model to explain the catch-bond behavior in 
thymocyte negative selection, outlined in Figure 35. The thymocyte begins at an initial 
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state where TCR and CD8 are separated on the cell surface and the CD3 tails for Lck 
binding are buried in the membrane. If there is no force on a TCR bond or a CD8 bond is 
pulled, no signaling occurs (Figure 35A, No Signaling path) and the cell maintains the 
initial state. However, if a TCR is pulled, signaling occurs (summarized in Figure 35B), 
tails of nearby CD3 molecules are released from the membrane and phosphorylated, and 
TCR forms TCR:CD8 dimers through the interaction of Lck with CD3 (Figure 35A, 
Signaling path). It then has the ability to overcome diffusion limitations and form periods 
of upregulated bond lifetimes in the BFP assay through PDD formation.  
 




(A) Thymocyte membrane interactions. Thymocytes activate signaling upon TCR pulling 
which promotes release of CD3 tails into cytosol. These tails bind to Lck on the CD8 
tails, leading to pre-formed TCR:CD8(Lck) dimers which have the capacity to for PDD 
bonds. (B) Signaling interactions. Once TCR is pulled by a pMHC interaction, signaling 
occurs proximal to the TCR in the form of Lck (green shading). Additionally, the release 
of the tails promotes generic phosphatase activity (red shading) which builds to suppress 
Lck kinase activity, resulting in thymocyte reversion to initial state. 
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This proposed mechanism corresponds with the outcomes of the data analyses and 
the literature. It combines aspects of TCR mechanotransduction, proximal signaling, and 
transient species deviations. In the next section, we will simulate this behavior and compare 
its results to the BFP data to explain the mechanism behind catch bonds in thymocyte 
negative selection. 
6.4.2 Simulations on proposed mechanism 
First, an algorithm was developed to simulate the results of the BFP assay. BFP is 
a unique assay in that there is a significant element of stochasticity to bond formation – 
different bonds can be pulled, at different times, for different durations – measured 
sequentially to output the static representation of a lifetime vs. force curve. The algorithm 
is outlined in Figure 36. It begins by initializing the two surfaces – thymocyte and bead – 
with their respective molecular densities, kinetics, and other inputs. The simulation models 
the contact between cell and bead by permitting transmembrane interactions for a period 
of time. After the contact period, the simulation determines presence, or lack, of a bond 
and its species. If the bond does not survive pulling or there is no bond, no lifetime is 
recorded and the system transitions to a waiting time module where signalling and 
modifications are permitted, but no transmembrane interactions can be formed (i.e. no 
binding to MHC). If the bond survives pulling, a lifetime is selected from the survival 
distribution for that bond and recorded. The thymocyte may signal during this time to 
modify the TCR for CD8 binding and activate Lck or phosphatase. After the bond time is 
finished, the simulation returns to the waiting time model. This can be repeated many times 
to create a sequence of bond lifetimes for a single cell-bead pair. In essence, this reflects 
the process of approach-contact-pull-clamp-wait cycle of the BFP force-clamp assay. 
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Figure 36. BFP simulation algorithm flow diagram 
 
Several different methods are used to evaluate the modules presented in the 
algorithm. The contact time, waiting time, and bond time modules are solved through a 
system of ordinary differential equations (ODEs) representing the first or second order 
interactions outlined in Figure 37 and solved with the ode45 function in Mathworks Matlab 
(R2015b). The probability of bond formation at the end of contact is determined from the 
total average number of bonds from the ODE system and assuming a Poisson model of the 
number of binding events [123]. The bond type is governed by weighted random selection 
from the relative fractions of bonds at the end of contact. Bond pulling survival probability 
was determined by integrating the expression for the rupture probability distribution at a 
The algorithm begins at the initialization module and proceeds in the direction indicated 
by the arrows. Each module is outlined in a rectangle. This can be repeated many times 
in sequence to replicate the experimental conditions of the micropipette assay. 
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given ramping rate [149] to the clamping force. The bond lifetime was selected from the 
Markov chain (Figure 33) by setting the appropriate initial species vector. The kinetics of 
individual interactions under force were determined through fitting to the Bell model [146].     
 
Figure 37. Outline of system interactions 
Parameters for the model are outlined in Table 7. Most the values are experimental 
conditions or measured by other assays. Others were selected from the appropriate 
literature or estimated.  
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Table 7. Simulation parameters for CD8 thymocyte binding mechanism 
 
The TCR signaling capacity requires a force-induced response. To estimate an 
appropriate function for this response, we looked to the catch-bond-like shape of the 
fraction of PDD bonds with force. The response fit very well to a gamma distribution 
(Figure 34). Additionally, several studies have indicated that T cells have a specific cellular 
response to force through their TCR [92, 93]. An optimal force is required on the TCR 
through the MHC to produce adequate downstream calcium flux; forces falling outside this 
range, whether higher or lower, do not signal. For these reasons, we decided to use the 
gamma function to approximate TCR mechanotransduction. The activation of Lck was 
given a response governed by the force on the TCR:pMHC bond (Figure 38). Other 
parameters were either measured, taken from literature, estimated, governed by assay 
conditions, or fit to data trends (see Experimental materials and methods, Table 7).  
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Figure 38. TCR:pMHC force induced Lck activation function 
To examine the trends of the simulations on catch bond behavior, we focused on 
two ligands on the edges of the selection threshold for the wild-type OT-1 system, Q4H7 
(positively selecting ligand) and Q4R7 (negatively selecting ligand). Simulation trends 
matched the experimental data trends very well (Figure 39). With low amounts of CD8:Lck 
conjugation (wild-type OT-1 thymocytes) Q4H7 simulations showed a slip bond, while 
Q4R7 simulations showed a catch bond behavior. If the only the fraction of CD8:Lck 
conjugation was increased while all other parameters remained the same, Q4H7 shifted its 
behavior to a catch bond, and Q4R7 made a much stronger catch bond (Figure 40). This is 
consistent with the experimental data.  
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Figure 40. Simulated BFP data indicates high Q4R7 sensitivity to mechanism 
 
6.5 Discussion and future studies 
Significant technical constraints limit the interpretation of BFP data in the context of 
multiple-bond interactions such as in the CD8-TCR-MHC system. This difficulty begins 
with the fact that many different bonds can be formed, and any bond under force could be 
Experimental (blue circles, error bars represent standard error) vs. Simulation (red circles, 
error bars represent 95% CI) force vs. lifetime curves for high Q4R7 with high (A, CD8.4) 
or low (B, wild-type CD8) CD8:Lck conjugation, and Q4H7 with high (C, CD8.4) or low 
(D, wild-type CD8) CD8:Lck conjugation.  
 
BFP data was simulated varying the CD8:Lck conjugation fraction (f) for Q4R7 (A) and 




one of many different species, even switching between states after the bond is clamped. 
Because the assay only measures bond lifetime and force levels, the type of bond, whether 
it be TCR:MHC, CD8:MHC, trimolecular, etc., cannot be determined. Compiling the data 
into lifetime vs. force curves provides some interpretation of the system mechanisms, but 
binning data loses a significant portion of information. Basic intuition reasons that force 
increases bond lifetime, thereby permitting more time for signal processing by the cell. 
However, due to the complexity of multiple bond types, this type of analysis falls short. By 
including some of this lost information in the form of survival distribution analysis, we 
have revealed a new mechanism in the TCR:CD8:MHC system and elucidated the origins 
of the thymocyte catch-bond behavior. 
The situation of antigen presentation in the thymus is much different from the BFP 
assay. For example, the BFP assay limits pMHC density to maintain a low binding 
frequency; this maintains single bond pulling. Only a single bond is pulled at a time whilst 
other TCR:pMHC interactions are not permitted. Only one pMHC species is present in the 
assay. In contrast, thymic antigen presentation allows multiple TCR:pMHC interactions to 
occur simultaneously with many different pMHC species, random or differential 
waveforms in mechanical bond loading, interactions with cytokines and other receptors, 
and all the additional complexities of in vivo cell-cell interactions. Nevertheless, the high 
resolution and control afforded by the BFP assay provides a unique platform for highly-
controlled probing of the cell, resulting in insights into thymic TCR antigen recognition 
otherwise unattainable through conventional approaches.  
The analysis on the BFP data presented in this chapter implicates TCR:pMHC 
forced-induced binding of CD8:Lck to TCR for longer lifetimes and antigen processing 
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(Figure 35). This new mechanism has many implications in thymic selection. Most 
coreceptor mechanism research has relied on non-thymocytes, but the mechanisms 
occurring at the thymocyte level are likely similar. In support of this mechanism, similar 
coreceptor CD4 (also conjugated to Lck) became more proximal to TCR after stimulation 
in primary T cell blasts [147]. Similarly, different ligands recruit CD8 to the immunological 
synapse with different time delays, with weaker ligands taking longer than stronger ligands, 
but approximately to the same level [150]. Casas and colleagues showed CD3 and CD8 
increased FRET signaling after T cell hybridoma stimulation by APCs [109]. Interestingly, 
they showed that this proximity change relied on CD8:Lck conjugation, as mutants 
removing the binding site eliminated the increase. However, the coreceptor-scanning 
concept, that a TCR:pMHC bond must last long enough to “scan” coreceptors for one 
bound to Lck for efficient signaling transmission, has gathered wide support [111, 112]. 
Figure 30 indicates this mechanism is unlikely to explain the BFP data. The mechanism 
presented in this study was not previously fathomable due to the nature of the assays, but 
it is still consistent with their experimental data. The analysis presented here does not 
exclude coreceptor scanning from contributing, albeit to a lesser degree.  
There are several implications of the proposed mechanism, outlined below. 
1) CD8:Lck conjugation regulates antigen sensitivity by TCR:CD8 conjugation 
capacity. In the BFP assay, conjugation controls the capacity of TCR and CD8:Lck 
to form dimers independent of direct pMHC contact. In vivo, the situation would 
be similar. Weak bonds would not elicit much response, but once a strong bond is 
pulled, CD8 and TCR would begin dimerization. A higher CD8:Lck fraction would 
allow more TCR-CD8 dimerization, increased pMHC sampling and higher 
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likelihood of rebinding that same antigen. It has previously been shown that this 
fraction varies between T cell subtypes [101, 148]. This indicates a control point 
for antigen sensitivity amplification.  
2) Control over the non-kinase binding of Lck to TCR(CD3) is critical. 
Phosphorylation of ITAMs by Lck modifies their charge and negates membrane 
sequestration of the tails which contain a basic residue sequence for Lck unique 
domain motif binding [49, 151]. Because this is a recently discovered interaction, 
control mechanisms are currently unknown, but Lck conformational states changes 
by phosphorylation or modifications due to CD8 binding are likely candidates. 
There is also significant evidence that CD3 ITAM-bound ZAP-70 mediates the 
interaction with Lck(CD8) [144, 145, 152]. The nature of the simulations does not 
preclude this interaction – Lck activation of TCRs could lead to ZAP-70 
recruitment, which would require one additional linear TCR modification to the 
model and therefore not change the outcome. Dissemination of these two 
possibilities could be a focal point for future research.  
3) Intracellular signaling dynamics controls CD3 tail stabilization and TCR-CD8 
dimerization. Lck is a likely candidate for stabilization due to its kinase activity. 
However, the generic phosphatase presented in the model is unknown. Likely 
candidates include Shp-1 or Shp-2 [52, 83, 84]. The interaction networks for these 
phosphatases are tightly controlled systems regulated by many different receptors 
and other signaling molecules [153].  
4) The proposed mechanism results in periods of TCR-CD8 dimerization, followed 
by dissociation and desensitization due to low bond number and lack of continuous 
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stimulation during the BFP assay. There is some evidence for this from the BFP 
data, but the data is not conclusive and more statistical analyses are required. In 
vivo, it would likely manifest as a stochastic and fast increase in dimerization 
which, depending on the amount of antigen present, may not contain a 
desensitization period if there is sufficient stimulation. 
5) This mechanism produces a second layer of regulation to the initial TCR triggering 
process. In effect, the TCR triggering occurs first, followed by TCR:CD8 
dimerization. This process induces an upregulated binding state for antigen 
recapture, similar to rebinding models discussed in Section 2.3.3. Therefore, a 
single TCR-pMHC interaction can trigger the response, but more TCR interactions 
are likely necessary for prolonged signaling and full T cell activation. 
There are several limitations to the simulation-based analysis presented in this 
chapter. First, it is difficult to control aspects of membrane organization in simulations due 
to computational resource constraints. This analysis does not preclude the possibility of 
membrane spatial control – i.e. if TCR force dynamics result in changes to the spacing 
between TCR and CD8, decreasing the effective binding rates. However, there must be 
some control over either there spacing or kinetics which is induced by force on a 
TCR:pMHC bond. In the simulations, this mechotransduction was produced through Lck 
activity, and is the most likely candidate at this time. Lck activity upregulates after TCR 
simulation, possibly through kinetic segregation methods (Section 2.3.2), but the exact 
mechanism is not known at this time. Additional studies are required to elucidate more 
about this mechanotransduction mechanism. Secondly, there are many parameters drawn 
from relevant literature, but the model was fit exclusively to two parameters – the interplay 
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between TCR-induced Lck activation and the generic phosphatase rates. Small changes to 
these parameters results in significant changes to the magnitude of the response. Therefore, 
it is important to note that the simulation results are indicative of larger trends resulting 
from the mechanism rather than a definitive quantitative description.  
In this chapter, we have presented the first evidence that mechanical forces on TCRs 
by pMHC can trigger a second level of antigen sensitivity regulation by inducing TCR and 
CD8 to dimerize through Lck:CD3 conjugation in thymocytes. Future studies will focus 
on validating this mechanism either by evidence of periods long-bond formation using the 
HAFM in its force-clamp capacity or direct evidence of CD8-TCR proximity changes after 
TCR mechanotransduction using FRET techniques and/or super-resolution microscopy 
cross-correlation analyses.  
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CHAPTER 7. CONCLUSIONS AND FUTURE DIRECTIONS 
Fixed kinetic rates are considered in nearly every analysis of TCR triggering and 
activation [71, 79-83, 85, 111]. In this study, we have shown several pieces of evidence 
that indicate that the kinetics governing the TCR antigen recognition process are much 
more complicated than originally conceived. In the absence of sustained force, TCRs 
upregulate their kinetics for fast intervals upon initial antigen recognition. Pharmacological 
intervention revealed that the most proximal TCR signaling molecules, Lck and 
cholesterol, play a significant role in regulating these periods. Additionally, mechanical 
force exerted on the TCR through pMHC recruits CD8 to proximal TCRs, inducing further 
sensitivity changes over time. This mechanism increases antigen capture as well as extends 
lifetime for proofreading. 
Although not studied directly in this work, these two mechanisms intersect on many 
levels. Both mechanisms involve Lck signaling and specific membrane organization. Both 
mechanisms develop in response to initial antigen recognition. Both mechanisms increase 
sensitivity for antigen recapture, both while maintaining ample discrimination capabilities. 
There are many basic questions that come from these mechanisms: At what level are these 
mechanisms controlled – DNA, microenvironment, other receptors? Is ligand memory 
impacted by mechanical forces similar to CD8? Which mechanism is more dominant 
during which stages of antigen recognition? These questions expose important challenges 
in informing therapeutic treatments. For instance, if we understand how these mechanisms 
controlling sensitivity are modulated in the human body, we can develop therapeutics 
targeting control points for either enhanced or suppressed T cell activation – an effect that 
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can be critical for pathogen clearance or limiting autoimmune damage, respectively. 
Additionally, a better understanding of these mechanisms would lead to more informed 
treatments. If TCR ligand memory is critical at the tonic signaling level, suppression would 
lead to cell death; however, if TCR force-induced CD8 recruitment follows, then 
suppression of this mechanism, while not affecting TCR ligand memory, would allow for 
cell survival but decreased TCR sensitivity. The sequencing of these mechanisms and their 
respective interactions is therefore critical for translational research and should be a focus 
of future studies. 
This work directly couples with antigen recognition in T cells; however, it also 
revealed the possibility of new mechanisms underlying other ligand-receptor binding 
interactions. Although not shown in these studies, several other receptor-ligand systems 
showed a positive memory index, and others exhibited changes to binding quality over 
time due to mechanotransduction. The unique assays used to parse these mechanisms are 
tedious and  require extensive training, unlike many standardized techniques available 
today, such as flow cytometry and blotting techniques. Therefore, it is unlikely that all 
receptor-ligand interactions can be probed at this level; even the studies presented here 
provide an incomplete picture. However, these mechanisms should be considered in the 
interpretation of systems requiring high sensitivity and discrimination; they likely rely on 
multiple layers of regulation originating from the first few binding events, and not wholly 
on signaling pathways.  
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APPENDIX A. MATLAB CODE FOR SIMULATION OF TCR 
MEMORY MECHANISM 
A.1 Code for cholesterol binding model 
% Simulate the micropipette binding assay  
% Create files outputting the adhesion frequency for each cluster over 
time 
% Written by William Rittase 
  
clearvars; close all 
  
%% Inputs 
n_times = 20; % number of cell pairs to simulate 
n_touches = 300; % number of touches per cell pair 
s = 120; % number of Latin hypercube divisions 
export_folder = 'insert folder string’; 
  
%% Input necessary folders 




%% Micropipette conditions 
tc = [0.25,5]; % contact time min and max 
tw = [1,6]; % waiting time min and max 
Ac = 1; % simulation contact area 
  
mT = 108; % density TCR 
mM = 2700; % density MHC 
  
n_clusters_to_sim = round(mT*Ac/13.5); % number of clusters in each 
cell pair 
  
%% Cluster probability distribution 
minClustSize = 7; 
maxClustSize = 20; % maximum cluster size from Davis paper 
clust_area_ratio = 0.07;  
r_t_ratio = pi*clust_area_ratio^2/maxClustSize; % maximum cluster area 
from Davis paper, 70nm radius (assume 20 TCRs) 
  
%% Binding Parameters 
  
D = 0.001; % diffusion constant in um^2/s 
  
% Scanning parameters (to be fit from statistical model) 
  
kt_f_norand = logspace(-8,-5,s); % on rate for TCR:MHC binding 
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kt_r_norand = logspace(-1,1,s); % off rate for TCR:MHC binding 
  
ktx_r_norand = logspace(-2,2,s); % off rate for xTCR:MHC binding 
  
ktx_f_norand = logspace(0,3,s); % on rate for xTCR:MHC binding 
  
kd_norand = logspace(-2,2,s); % transformation constant -> reversion 
from xTCR to TCR cluster 
  
kc_norand = logspace(-2,2,s); % conversion rate for cluster TCR -> xTCR 
  
%% Inport v and R vectors 
v = xlsread('v_6.xlsx'); 
R_start = xlsread('R_6.xlsx'); 
  
%% Species vector (m) 
% 1: TCR, unbound low affinity TCR 
% 2: TCRx, unbound higher affinity TCR 
% 3: TCR:MHC, bound TCR:MHC, no phos 
% 4: TCRx:MHC, bound TCR:MHC, phos 
% 5: MHC, unbound MHC 
% 6: Placeholder, always 1: used for diffusion of MHC, conversion of 
% cluster (reactions 5 and 6) 
  
% Get from get_molec_species_modelx 
  
bonds = logical([0,0,1,1,0,0]); % which species are bonds 
  
%% Kinetic vector (k) 
% 1: TCR:MHC binding 
% 2: TCR:MHC unbinding 
% 3: TCRx:MHC binding 
% 4: TCRx:MHC unbinding 
% 5: Conversion coefficient (coverting cluster TCR->xTCR) 
% 6: Degrading coefficient (coverting cluster xTCR->TCR) 
% 7: MHC diffusion out 
% 8: MHC diffusion in 
  
% Get from get_kinetics_parameters_modelx 
  
%% Randomize parameters 
kt_r_scan = kt_r_norand(randperm(length(kt_r_norand))); 
kt_f_scan = kt_f_norand(randperm(length(kt_f_norand))); 
kc_scan = kc_norand(randperm(length(kc_norand))); 
ktx_f_scan = ktx_f_norand(randperm(length(ktx_f_norand))); 
ktx_r_scan = ktx_r_norand(randperm(length(ktx_r_norand))); 
kd_scan = kd_norand(randperm(length(kd_norand))); 
  
for i = 1:s % for each scanning condition 
    kt_r = kt_r_scan(i); 
    kc = kc_scan(i); 
    kd = kd_scan(i); 
    kt_f = kt_f_scan(i); 
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    ktx_f = ktx_f_scan(i)*kt_f; 
    ktx_r = kt_r*ktx_r_scan(i); 
     
    for n1 = 1:n_times 
     
        af = zeros(n_clusters_to_sim,n_touches); 
        ct = (tc(2)-tc(1))*rand(1,n_touches)+tc(1); 
        wt = (tw(2)-tw(1))*rand(1,n_touches)+tw(1); 
         
        tic 
     
        for n2 = 1:n_clusters_to_sim % for each cluster 
             
            [m,A_clust] = get_molec_species_model6(mM, minClustSize, 
maxClustSize, r_t_ratio); 
            [k_on,k_off] = get_kinetic_parameters_model6(mM, kt_f, 
kt_r, ktx_f, ktx_r, kc, kd, D, A_clust); 
             
            R = R_start; 
             
            m_start = m; 
  
            for n3 = 1:n_touches 
                % contact time 
                m_on = one_touch_model6(m,k_on,ct(n3),R,v); 
                % if there was a bond 
                if sum(m_on(bonds)) > 0  
                    af(n2,n3) = 1; 
                    % break bonds 
                    m = m_on; 
                    m(1) = m(1)+m(3); 
                    m(2) = m(2)+m(4); 
                    m(3) = 0; 
                    m(4) = 0; 
                    m(5) = m(3)+m(4)+m(5); 
                else 
                    m = m_on; 
                end 
                % waiting time 
                m = one_touch_model6(m,k_off,wt(n3),R,v); 
            end 
        end 
         
        % export data to folder 
        folder_now = [export_folder,'/Condition ',num2str(i),'/','Cell 
Pair ',num2str(n1),'/']; 
  
        if ~isdir(folder_now) 
            mkdir(folder_now) 
        end 
         
        csvwrite([folder_now,'af'],af) 
        csvwrite([folder_now,'ct'],ct) 
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        csvwrite([folder_now,'wt'],wt) 
         
        disp(['s = ',num2str(i)]) 
        disp([num2str(n1),' of ',num2str(n_times),' Runs Completed.']) 
        disp(['Time Elapsed = ',num2str(toc)]) 
         








A.2 Code for get kinetic parameters function 
function [k_on,k_off] = get_kinetic_parameters_model6(mM, kt_f, kt_r, 
ktx_f, ktx_r, kc, kd, D, A_clust) 




% Output kinetics format (k_on or k_off where on = cells in contact, 
off = 
% cells not in contact) 
% 1: TCR:MHC binding 
% 2: TCR:MHC unbinding 
% 3: TCRx:MHC binding 
% 4: TCRx:MHC unbinding 
% 5: Conversion coefficient (coverting cluster TCR->xTCR) 
% 6: Degrading coefficient (coverting cluster xTCR->TCR) 
% 7: MHC diffusion out 
% 8: MHC diffusion in 
  
%% k_on 
     
    k_on = zeros(1,8); 
     
    k_on(1) = kt_f/A_clust; 
    k_on(2) = kt_r; 
    k_on(3) = ktx_f/A_clust; 
    k_on(4) = ktx_r; 
    k_on(5) = kc; 
    k_on(6) = kd; 
     
    Mavg = mM*A_clust; % average MHC in cluster 
  
    k_on(7) = D/A_clust; % diffusion rate out 
     
    k_on(8) = k_on(7)*Mavg; % diffusion rate in 
     
%% k_off 
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    k_off = zeros(1,8); 
     
    k_off(1) = 0; 
    k_off(2) = 0; 
    k_off(3) = 0; 
    k_off(4) = 0; 
    k_off(5) = 0; 
    k_off(6) = kd; 
     
    Mavg = mM*A_clust; % average MHC in cluster 
  
    k_off(7) = D/A_clust; % diffusion rate out 
     
    k_off(8) = k_on(7)*Mavg; % diffusion rate in 
  
end 
A.3 Code for one touch function 
function m_out = one_touch_model6(m,k,t_max,R,v) 
% simulate one touches using input vectors and kinetics for time t 
% m = species vector 
% k = kinetics vector 
% t_max = contact/waiting time 
% R = proportions required for ssa evalulation 
% v = species change vector 
  
t = 0; 
stop = 0; 
  
n = 0; 
  
while stop == 0 
     
    n = n+1; 
     
    [m_new,dt,rxn] = ssa_model6(m,v,k,R); 
     
    if t+dt > t_max % if time is exceeded, stop and output 
        m_out = m; 
        stop = 1; 
    elseif (t+dt < t_max) && (rxn ~= 5) && (rxn ~= 6) 
        m = m_new; 
        t = t+dt; 
    elseif rxn == 5 % if conversion of cluster from TCR to xTCR 
        m(2) = m(1); 
        m(1) = 0; 
        m(4) = m(3); 
        m(3) = 0; 
        R(6,end) = 1; % need to change R so that degrading is in 
    elseif rxn == 6 % if conversion of cluster from xTCR to TCR 
        m(1) = m(2); 
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        m(2) = 0; 
        m(3) = m(4); 
        m(4) = 0; 
        R(6,end) = 0; % need to change R so that degrading is out 





A.4 Code for SSA function 
function [Xnew,dt,iEvent] = ssa_model6(X,v,k,R) 
% Perform the stochastic simulation algorithm from Gillepsie and output 
new 
% species vector and rate constant vector 
% X is species vector 
% k is kinetics vector 
% v is change of species vector  
% R is species vector for propensities determination 
  
P = zeros(size(k)); 
  
for i = 1:length(k) 
    Ri = R(i,:); 
    ri = Ri > 0; 
     
    if sum(ri)>0 
     
        P(i) = k(i) * prod(X(ri).*Ri(ri)); 
         
    end 
end 
     
Psum = cumsum(P); 
dt = - log(rand)/Psum(end); % time step for next reaction 
r = rand*Psum(end); 
iEvent = length(Psum(Psum<r))+1; % choose reaction that fires 
  
Xnew = X + v(iEvent,:); 
  
end 
A.5 Code for model evaluation script 
% Use the outputs from cholester binding model to determine the 
adhesion 
% frequency 








n_cond = 120; 
n_times = 20; 
n_clusters_to_sim = 8; 
  
%% Necessary folders 
  
data_folder = 'insert folder string'; 
  
%% Begin af evaluation for each condition 
for i = 1:n_cond 
    af_all = []; 
    wt_all = []; 
    ct_all = []; 
     
    current_folder = [data_folder,'Condition ',num2str(i),'/']; 
     
    for j = 1:n_times 
        current_folder_cp = [current_folder,'Cell Pair 
',num2str(j),'/']; 
         
        % read simulation data files from current folder cp (cell pair 
        % designation) 
         
        af_now = csvread([current_folder_cp,'af']); % adhesion 
frequency for each cluster 
        wt_cp = csvread([current_folder_cp,'wt']); % wating times for 
cell pair 
        ct_cp = csvread([current_folder_cp,'ct']); % contact times for 
cell pair 
         
        % Determine actual adhesion frequency for cell pair based on 
all 
        % the clusters - if one cluster is bound, then a binding event 
        % occurred 
         
        afs_now = sum(af_now,1);  
        af_cp = afs_now>0; % cell pair adhesion frequency 
         
        % Put together data sets 
        af_all = [af_all;af_cp]; 
        wt_all = [wt_all;wt_cp]; 
        ct_all = [ct_all;ct_cp]; 
         
    end 
     
    csvwrite([current_folder,'af_all'],af_all) 
    csvwrite([current_folder,'ct_all'],ct_all) 
    csvwrite([current_folder,'wt_all'],wt_all) 
     
end 
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A.6 Code for memory index evaluation and plotting script 
% Evaluate the adhesion frequency from model_evaluation_af to extract 
% memory index 






n_cond = 120; 
n_times = 20; % equivalent to n cell pairs 
af_plot = 0; % if plotting distribution for adhesion frequency 
dp_plot = 0; % if plotting distribution 
af_vs_dp_plot = 1; 
  
%% Necessary folders 
  




dp = zeros(n_cond,n_times); 
af = zeros(n_cond,n_times); 
  
%% Go condition by condition 
for i = 1:n_cond 
    % Import data 
    current_folder = [data_folder,'Condition ',num2str(i),'/']; 
    af_folder = csvread([current_folder,'af_all']); 
     
    % Go cell pair by cell pair 
    for j = 1:n_times 
        af_now = af_folder(j,:); 
        % for each touch after the first,  
        n11 = 0; 
        n10 = 0; 
        n01 = 0; 
        n00 = 0; 
        for k = 2:length(af_now) 
             
            if af_now(k) == 1 
                if af_now(k-1) == 0 
                    n01 = n01+1; 
                else 
                    n11 = n11+1; 
                end 
            elseif af_now(k) == 0 
                if af_now(k-1) == 0 
                    n00 = n00+1; 
                else 
                    n10 = n10+1; 
                end 
            end 
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        end 
         
        p11 = n11/(n10+n11); 
        p01 = n01/(n01+n00); 
         
        dp(i,j) = p11-p01; 
         
        af(i,j) = mean(af_now); 
         
    end 
     
end 
  
dp = dp'; 





dp_mean = mean(dp,1); 
af_mean = mean(af,1); 
  
scanned_parameters = csvread([data_folder,'all variables']); 
  
if dp_plot == 1 
    subplot(3,2,1) 
    scatter(scanned_parameters(1,:),dp_mean) 
    title('kT_r') 
    a = gca; 
    a.XScale = 'log'; 
  
    hold all 
  
    subplot(3,2,2) 
    scatter(scanned_parameters(2,:),dp_mean) 
    title('kT_f') 
    a = gca; 
    a.XScale = 'log'; 
  
    subplot(3,2,3) 
    scatter(scanned_parameters(3,:),dp_mean) 
    title('kTx_r') 
    a = gca; 
    a.XScale = 'log'; 
  
    subplot(3,2,4) 
    scatter(scanned_parameters(4,:),dp_mean) 
    title('kTx_f') 
    a = gca; 
    a.XScale = 'log'; 
  
    subplot(3,2,5) 
    scatter(scanned_parameters(5,:),dp_mean) 
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    title('k_c') 
    a = gca; 
    a.XScale = 'log'; 
  
    subplot(3,2,6) 
    scatter(scanned_parameters(6,:),dp_mean) 
    title('k_d') 
    a = gca; 
    a.XScale = 'log'; 
end 
  
if af_plot == 1 
    subplot(3,2,1) 
    scatter(scanned_parameters(1,:),af_mean) 
    title('kT_r') 
    a = gca; 
    a.XScale = 'log'; 
  
    hold all 
  
    subplot(3,2,2) 
    scatter(scanned_parameters(2,:),af_mean) 
    title('kT_f') 
    a = gca; 
    a.XScale = 'log'; 
  
    subplot(3,2,3) 
    scatter(scanned_parameters(3,:),af_mean) 
    title('kTx_r') 
    a = gca; 
    a.XScale = 'log'; 
  
    subplot(3,2,4) 
    scatter(scanned_parameters(4,:),af_mean) 
    title('kTx_f') 
    a = gca; 
    a.XScale = 'log'; 
  
    subplot(3,2,5) 
    scatter(scanned_parameters(5,:),af_mean) 
    title('k_c') 
    a = gca; 
    a.XScale = 'log'; 
  
    subplot(3,2,6) 
    scatter(scanned_parameters(6,:),af_mean) 
    title('k_d') 
    a = gca; 
    a.XScale = 'log'; 
end 
  
if af_vs_dp_plot == 1 
    scatter(af_mean,dp_mean) 
    xlabel('Adhesion Frequency') 




APPENDIX B.  MATLAB CODE FOR MARKOV CHAIN 
SURVIVAL DISTRIBUTION FITTING 
B.1 Code for fitting algorithm  
% Run best fit for species holding kenh constant 
% Assume it starts in variable state 
% Fit distribution, not average lifetime 
  
% Written by William Rittase 
% January 23, 2018 
  
% Important outputs: 
% fracTMC_best: best fitting fraction of PDD bonds, fracTMC_best is a 
cell 
% vector with fracTMC_best{i} containing the best fit solutions for 
% file{i}. See scan_model_check_hold_kenh function for contents of 
% fracTMC_best{i} 
% pBest: best survival distributions probabilities, pBest is a cell 
vector 
% with pBest{i} containing the best fit solutions for file{i}. See 
% scan_model_check_hold_kenh 
% tBest: best survival distributions times, pBest is a cell vector 
% with pBest{i} containing the best fit solutions for file{i}. See 
% scan_model_check_hold_kenh 
  
clearvars; close all 
  
%% Add data and function paths 
dataPath = 'input folder for data'; 
functionPath = 'input folder for functions'; 






%% Inputs (starting probabilities vector) 
  
numCond = 8; 
fracTMC_best = cell(numCond,1); 
tBest = cell(numCond,1); 
pBest = cell(numCond,1); 
F = cell(numCond,1); 
names = cell(numCond,1); 
  




file = 'wQ4'; 
n = n+1; 
[F{n},~,~,~,~,~,~] = readData_v3(file); 
  
% Kinetic rates (force-free) 
kf_tm = 0.0000899378/6;  
kr_tm = 4.22;          
f_T = 30.2; 
% Initial condition 




names{n} = file; 
  
%% wQ4R7 
file = 'wQ4R7'; 
n = n+1; 
[F{n},~,~,~,~,~,~] = readData_v3(file); 
  
% Kinetic rates (force-free) 
kf_tm = 0.000135225/6;  
kr_tm = 3.45; 
f_T = 72.3; 
% Initial condition 




names{n} = file; 
  
%% wT4 
file = 'wT4'; 
n = n+1; 
[F{n},~,~,~,~,~,~] = readData_v3(file); 
  
% Kinetic rates (force-free) 
kf_tm = 0.0000592144/6;  
kr_tm = 2.75;         
f_T = 13; 
% Initial condition 




names{n} = file; 
  
%% Run wQ4H7 
file = 'wQ4H7'; 
n = n+1; 
[F{n},~,~,~,~,~,~] = readData_v3(file); 
  
% Kinetic rates (force-free) 
kf_tm = 0.0000706784/6; % fit from other data 
kr_tm = 4.15; % fit from other data 
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f_T = 30.8; 
% Initial condition  




names{n} = file; 
  
%% wQ7 
file = 'wQ7'; 
n = n+1; 
[F{n},~,~,~,~,~,~] = readData_v3(file); 
  
% Kinetic rates (force-free) 
kf_tm = 0.0000457382/6;  
kr_tm = 6.72;          
f_T = 46.3; 
% Initial condition 




names{n} = file; 
  
%% wG4 
file = 'wG4'; 
n = n+1; 
[F{n},~,~,~,~,~,~] = readData_v3(file); 
  
% Kinetic rates (force-free) 
kf_tm = 0.0000542196/6;           
kr_tm = 3.63; 
f_T = 11.9; 
% Initial condition 




names{n} = file; 
  
%% wQ4R7 
file = 'wQ4R7_8p4'; 
n = n+1; 
[F{n},~,~,~,~,~,~] = readData_v3(file); 
  
% Kinetic rates (force-free) 
kf_tm = 0.000135225/6;  
kr_tm = 3.45; 
f_T = 72.3; 
% Initial condition 




names{n} = file; 
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%% Run wQ4H7 
file = 'wQ4H7_8p4'; 
n = n+1; 
[F{n},~,~,~,~,~,~] = readData_v3(file); 
  
% Kinetic rates (force-free) 
kf_tm = 0.0000706784/6; % fit from other data 
kr_tm = 4.15; % fit from other data 
f_T = 30.8; 
% Initial condition 









B.2 Code for gathering data function 
function [F,LT,var_LT,stderr_LT,Fstore,LTstore,pLT] = 
readData_v3(dataFile) 
% Read data from file dataFile and output it into a cell array 
% dataFile: string with name of file 
% F: F(i) is the mean force for bin i 
% lt: lt(i) is the average lifetime for bin i 
% var_lt: lt_var(i) is the variance of lifetime for bin i 
% Fstore = cell array where Fstore{i} = forces for bin i 
% LTstore = cell array where LTstore{i}(j) = lifetimes for force from 
%   Fstore{i}(j) 




addpath('input folder for matlab data') 
  
dataAll = load(dataFile); 
  
dataAll = dataAll.data; 
  
[~,y] = size(dataAll); 
  
numForces = y/4; 
  
F = zeros(numForces,1); 
LT = zeros(numForces,1); 
var_LT = zeros(numForces,1); 
stderr_LT = zeros(numForces,1); 
Fstore = cell(numForces,1); 
LTstore = cell(numForces,1); 
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pLT = cell(numForces,1); 
  
for i = 1:numForces 
    istart = (i-1)*4 + 2; 
    dataNow = dataAll(:,istart); 
     
    n = length(dataNow(dataNow>0)); 
    data = [dataAll(1:n,istart-1),dataAll(1:n,istart)]; 
     
    F(i) = mean(data(:,1)); 
    LT(i) = mean(data(:,2)); 
    stderr_LT(i) = std(data(:,2))/sqrt(n); 
    var_LT(i) = mean(data(:,2).^2) - mean(data(:,2))^2; 
    Fstore{i} = data(:,1); 
    LTstore{i} = data(:,2); 
     
    pLT{i} = zeros(1,n); 
    for j = 1:n 
        pLT{i}(j) = (n-j)/n; 
    end 
end 
B.3 Code for scanning parameter space 
function [fracTMC_best,pBest,tBest] = 
scan_model_check_hold_kenh(kr_tm,kf_tm,f_T,file,fracTMC_ic) 
  
%% This function runs the parameter scan for PDD bond fraction  
% Scans peptide data file string to find best fit for PDD bond fraction 
% coefficient 
% January 22, 2018 
% uses readData_v3, fitres_dist_model_check_hold_kenh, errorfx_v9, 
deqC_fs_Dinv3, mainsimulation_fs_Din_v5, deqC_fs_Din_v3 
% Inputs: 
% kr_tm = off rate for tcr-mhc interaction 
% kf_tm = on rate for tcr-mhc interaction 
% f_T = nominal force for TCR:MHC interaction in Bell model 
% file = file name (in folder dataPath) 
% fracTMC_ic = best fit initial conditions for fitting fraction of PDD 
% bonds 
% Outputs: 
% fracTMC_best: best fitting fraction of PDD bonds for each force 
% pBest: best fitting simulation probabilities for survival 
distribution, 
% cell vector where pBest{i} corresponds to force F(i) 
% tBest: best fitting simulation times for surival distribution, cell 
% vector where tBest{i} corresponds to force F(i) 
  
%% Load data 
[F,~,~,~,~,LTstore,pLT] = readData_v3(file); 
n = length(F); % number of forces 
errorType = 4; % way to calculate error (errorfx_v9) 
  




% Kinetic rates (force-free) 
kr_mc = 7.84; % CD8:MHC off rate 
kf_mc = 0.00004/6; % CD8 MHC on rate 
kr_tl = 0.1; % Lck:TCR off rate 
kf_tl = 1e-3; % Lck:CD8 on rate 
  
f_C = 21.9; % nominal force for Bell model 
  
t = 0:0.0001:10; % recording times for simulation 
t = t'; 
  
D = 0.08; % from Chakraborty/Palmer model 
  
% Densities 
mT = 8; % TCR density 
mC = 311; % MHC density 
  
f = 0.05; % fraction of CD8:Lck conjugation 
  
% Contact rate coefficients 
mC_0 = mC*(1-f); % unconjugated CD8 fraction 
mC_L = mC*f; % Lck conjugated CD8 fraction 
  
D_T = mT*D*pi; % TCR contact rate 
D_C0 = mC_0*D*pi; % CD8 null contact rate 
D_CL = mC_L*D*pi; % CD8:Lck contact rate 
  
kenh = 1500; % enhancement coefficient for rebinding 
  
fracTMC_best = fracTMC_ic; 
  
% Storage 
pBest = cell(n,1); 
tBest = cell(n,1); 
  
% Initial plot to be updated later 
semilogy(t,zeros(size(t)),LTstore{1},pLT{1},'o'); 
h = gcf; 
drawnow 
axesObj = get(h, 'Children');  %axes handles 
dataObj = get(axesObj, 'Children'); 
  
for j = 1:n % for each force condition    
    %% Run fitting around initial condtion until fitting condition is 
met, coarse scan 
    res_fracTMC = 0.1; 
    stop = 0; 
    run = 0; 
    errorLast = inf; 
     
    set(dataObj(1),'XData',LTstore{j}','YData',pLT{j}) 
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    drawnow 
     
    while stop == 0 




        axesObj.XLim = [0,max(LTstore{j})]; 
        axesObj.YLim = [pLT{j}(end-1),1]; 
        drawnow 
        disp(strcat('Run number',{' '},num2str(run),'|| Best Fit Now 
=',{' '},num2str(fracTMC_best(j)))) 
    end 
     
    %% Run fitting around initial condtion until fitting condition is 
met, fine scan 
    res_fracTMC = 0.01; 
    stop = 0; 
    run = 0; 
    errorLast = inf; 
  
    while stop == 0 




        axesObj.XLim = [0,max(LTstore{j})]; 
        axesObj.YLim = [pLT{j}(end-1),1]; 
        drawnow 
        disp(strcat('Run number',{' '},num2str(run),'|| Best Fit Now 
=',{' '},num2str(fracTMC_best(j)))) 
    end 
     
    file_path = strcat([file,'_',num2str(round(F(j)))]); 
    fig_path = [folder_path,file_path]; 
    savefig(fig_path) 
     
end 
  
disp(strcat('bestFit',{' '},file,{' '},'complete')) 
  
end 
B.4 Code for running the different cases and finding lowest residual function 





% Inputs come from scan_model_check_hold_kenh 
% res_fracTMC: resolution of fitting 
% kenh: enhancement coefficient 
% stop: marker to stop fitting 
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% run: run number, how many times this has run 
% F: force bins level 
% LTstore: lifetimes in force bin 
% pLT: probabilities in force bin 
% errorType: used for errorfx_v9 
% errorLast: error from last run 
% t: times to simulated survival distribution 
% f: fraction of CD8:Lck conjugation 
% kf/kr_tm: on and off rates for TCR:MHC binding 
% kf/kr_cm: on and off rates for CD8:MHC binding 
% f_C/T: nominal force for Bell model for CD8/TCR:MHC 
% D_out: diffusion out of the contact zone 
% D_T/C0/Cl: diffusion into contact zone for TCR,CD8null,CD8:Lck 
% dataObj: handle for figure 
 
% Outputs 
% fracTMC_out: best fitting PDD fraction 
% run: how many runs it took 
% stop: marker for checking completion 
% errorLast: error from last run 
% pAllBest: probabilities for survival distribution best fit 
% t_now: times for best fit survival distribution 
 
% January 22, 2018 
% Uses errorfx_v9, mainSimulation_fs_Din_v5, deqC_fs_Din_v3 
  
    run = run+1; 
  
    fracTMC_fit = round([fracTMC-
res_fracTMC,fracTMC,fracTMC+res_fracTMC],2); 
  
    gt0_fracTMC = fracTMC_fit>=0 & fracTMC_fit<=1; % res cannot pull 
out negative values 
  
    pAll = cell(3,1); 
     
    errorBest = inf; 
     
    mT = 8; 
    mC = 311; 
  
    for i = 1:3 
         
        if gt0_fracTMC(i) > 0 
  
            kenh_now = kenh; 
            fracTMC_now = fracTMC_fit(i); 
  
            mstart = zeros(12,1); 
            mstart(1) = fracTMC_now; 
            pT = kf_tm/kr_tm*mT; 
            pC = kf_mc/kr_mc*mC*(1-f); 
            pCL = kf_mc/kr_mc*mC*f; 
            sumAll = pT+pC+pCL; 
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            mstart(6) = (1-fracTMC_now)*pT/sumAll; 
            mstart(7) = (1-fracTMC_now)*pC/sumAll; 
            mstart(8) = (1-fracTMC_now)*pCL/sumAll; 
  




            mstore_now = sum(mstore,2); 
            LTstore = round(LTstore,4); 
            mstore_now2 = mstore_now(t>=min(LTstore)); 
            t_now = t(t>=min(LTstore)); 
            pAll{i} = mstore_now2/mstore_now2(1); 
  
            errorNow = errorfx_v9(pAll{i},pLT(1:end-
1),t_now,LTstore(1:end-1),errorType);    % 
errorfx_v2(pAllSim,pAllExp,tAllSim,tAllExp,errorType) 
  
            if i == 1 
                errorBest = errorNow; 
                fracTMC_out = fracTMC_fit(i); 
                iBest = i; 
            elseif errorNow < errorBest 
                errorBest = errorNow; 
                fracTMC_out = fracTMC_fit(i); 
                iBest = i; 
            end 
             
        end 
  
    end 
  
    if errorBest >= errorLast 
        fracTMC_out = fracTMC_fit(2); 
        pAllBest = pAll{2}; 
        stop = 1; 
    else 
        errorLast = errorBest; 
        pAllBest = pAll{iBest}; 
        set(dataObj(2),'XData',t_now,'YData',pAllBest) 
        drawnow 
    end 
  
end 
B.5 Code for simulating a single Markov chain function 




%% Simulation to analyze pseudo-dimer of dimers pulling experiment 
% Note: diffusion of molecules back in allowed 
% Same as v4 but faster due to no globalization of k 
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%% Inputs  
% mstart: initial species probabilities vector 
% t: time vector for lifetime (should be relatively fine resolution) 
% F: vector for forces to evalulate lifetime 
% kr_tm: unbinding tcr-mhc (zero force) 
% kf_tm: rebinding tcr-mhc 
% kr_mc: unbinding mhc-cd8 (zero force) 
% kf_mc: rebinding mhc-cd8 
% kr_tl: unbinding tcr-lck (zero force) 
% kf_tl: rebinding tcr-lck  
% k_increase: enhanced rebinding due to pdd 
% f_T: Bell model nominal force for TCR 
% f_C: Bell model nominal force for CD8 
% D_out: Diffusion constant input (in um^2/s) 
% D_C0: Contact rate for CD8 without LCK 
% D_CL: Contact rate for CD8 with LCK 
% D_T: Contact rate for TCR 
%% Outputs 
% mstore: m-by-1 cell vector with each cell containing n-by-p vector 
where 




% f = 10; % nominal force for Bell model, added as model input 
  
% Which bond 
kf_enhance = k_increase;  
  
L = 0.01; % length of confinement/"close" zone 
  
%% Normalization 
A = L^2; % area of confinement zone 
kf_tm_norm = kf_tm/A; 
kf_mc_norm = kf_mc/A; 
kf_tl_norm = kf_tl/A; 
D_norm = D_out/A; 
  
%% Storage 
mstore = cell(size(F)); % store markov results 
  
for i = 1:length(F) 
    kr_tm_now = kr_tm*exp(F(i)/f_T); 
    kr_mc_now = kr_mc*exp(F(i)/f_C); 
     
    kr_tm_fs = kr_tm*exp(F(i)/2/f_T); 
    kr_mc_fs = kr_mc*exp(F(i)/2/f_C); 
     
    k = [kf_tm_norm;... 
        kr_tm_now;... 
        kf_mc_norm;... 
        kr_mc_now;... 
        kf_tl_norm;... 
        kr_tl;... 
        kf_enhance;... 
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        D_norm;... 
        D_norm;... 
        D_norm; 
        kr_tm_fs;... 
        kr_mc_fs;... 
        D_CL;... 
        D_C0;... 
        D_T]; 
     
    m = mstart; 
     
    % species by ratio of affinities 
     
    % run to steady state 
    options = odeset('RelTol',1e-5,'AbsTol',1e-
7);%,'OutputFcn',@odewbar); 
     
    % run sim 
    [~,mo] = ode45(@(t,m)deqC_fs_Din_v3(t,m,k),t,m,options); 
     
    mstore = mo; 
     
end 
B.6 Code for finding error residuals function 
function [errorOut] = 
errorfx_v9(pAllSim,pAllExp,tAllSim,tAllExp,errorType) 
% Find error between simulation and experimental data 
 
% Inputs 
% pAllSim: simulated probability of lifetime for survival distribution 
% pAllExp: experimental probability of lifetime for survival 
distribution 
% tAllSim: simulated times for probability (pAllSim(i) corresponds to 
% tAllSim(i)) 
% tAllExp: experimental times for probability (pAllExp(i) corresponds 
to 
% tAllExp(i)) 




% errorOut: error from fitting based on error type 
 
% variance based fitting 
tAllSim = round(tAllSim,4); 
tAllExp = round(tAllExp,4); 
%% Weighted^2 Least squares error 
if errorType == 1 
    errorOut = 0; 
    for i = 1:length(pAllExp) 
        findi = length(tAllSim(tAllSim<=tAllExp(i))); % index of 
lifetimes in simulated data less than experimental lifetime (i) 
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        errorOut = errorOut + tAllSim(findi)^2*(pAllSim(findi)-
pAllExp(i))^2; 
    end 
end 
%% Pearson's chi-square 
if errorType == 2 
    errorOut = 0; 
    for i = 1:length(pAllExp) 
        findi = length(tAllSim(tAllSim<=tAllExp(i))); % index of 
lifetimes in simulated data less than experimental lifetime (i) 
         
        errorOut = errorOut + (pAllSim(findi)-
pAllExp(i))^2/pAllSim(findi); 
    end 
end 
%% Weighted Least squared error 
if errorType == 3 
    errorOut = 0; 
    for i = 1:length(pAllExp) 
        findi = length(tAllSim(tAllSim<=tAllExp(i))); % index of 
lifetimes in simulated data less than experimental lifetime (i) 
         
        errorOut = errorOut + tAllSim(findi)*(pAllSim(findi)-
pAllExp(i))^2; 
    end 
end 
%% Variance-based weighting 
if errorType == 4 
    weights = zeros(size(pAllExp)); 
    errorOut = 0; 
    variance_measurement = 0.1; 
    % find weights 
    for i = 1:length(pAllExp) 
        weights(i) = 1/(variance_measurement*pAllExp(i))^2; 
    end 
     
    norm_weights = weights./mean(weights); 
     
    for i = 1:length(pAllExp) 
        findi = length(tAllSim(tAllSim<=tAllExp(i))); % index of 
lifetimes in simulated data less than experimental lifetime (i) 
         
        errorOut = errorOut + norm_weights(i)*(pAllSim(findi)-
pAllExp(i))^2; 
    end 
end 
B.7 ODE equations for Markov transition  
function dm = deqC_fs_Din_v3(t,m,k) 
%% Differential equations for Markov chain evaluating Pseudo-dimer of 
dimers (pdd) model 
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% Enhancement of binding occurs to both TCR and CD8 and LCK under 
force, TCR and CD8 equally 
% share load when bound to MHC 
%% Kinetic parameter vector 
    % Single-molecule interactions 
    % 1: TCR:MHC binding 
    % 2: TCR:MHC unbinding 
    % 3: CD8:MHC binding 
    % 4: CD8:MHC unbinding 
    % 5: TCR:LCK binding 
    % 6: TCR:LCK unbinding 
    % 7: Rebinding enhancement if close 
    % 8: CD8:LCK diffuse out 
    % 9: CD8 diffuse out (no Lck) 
    % 10: TCR diffuse out 
    % 11: TCR:MHC unbinding (with force share) 
    % 12: CD8:MHC unbinding (with force share) 
    % 13: CD8:LCK diffuse in 
    % 14: CD8 diffuse in 
    % 15: TCR diffuse in 
%% Species vector 
    % 1: TCR-MHC-CD8-LCK 
    % 2: TCR-MHC-LCK (CD8 close) 
    % 3: MHC-CD8-LCK (TCR close, bound LCK) 
    % 4: TCR-MHC-CD8 (LCK close) 
    % 5: TCR-MHC-CD8 (no LCK)  
    % 6: TCR-MHC (CD8 diffused away) 
    % 7: MHC-CD8 (no LCK) (TCR diffused away) 
    % 8: MHC-CD8-LCK (TCR diffused away) 
    % 9: TCR-MHC (CD8 close, no Lck) 
    % 10: TCR-MHC (CD8 close, with Lck) 
    % 11: CD8-MHC-LCK (TCR close, unbound to anything) 
    % 12: CD8-MHC (TCR close, unbound, no LCK) 
     
  
%% equations 
% Notes: m = [m1,m2...], kinetics = [k1,k2...]  
     
    dm = zeros(size(m)); 
     
    dm(1) = -k(11)*m(1) - k(12)*m(1) - k(6)*m(1) + k(1)*k(7)*m(3) + 
k(3)*k(7)*m(2) + k(5)*k(7)*m(4); % TCR unbinds, CD8 unbinds, LCK 
unbinds, TCR rebinds, CD8 rebinds, LCK rebinds, 
    dm(2) = -k(3)*k(7)*m(2) - k(6)*m(2) - k(2)*m(2) + k(12)*m(1) + 
k(5)*m(10); % CD8 rebinds, LCK unbinds, TCR unbinds, CD8 rebinds (CD8 
unbinds m1, LCK rebinds when close) 
    dm(3) = -k(1)*k(7)*m(3) - k(4)*m(3) - k(6)*m(3) + k(11)*m(1) + 
k(5)*m(11);  
    dm(4) = -k(5)*k(7)*m(4) - k(11)*m(4) - k(12)*m(4) + k(6)*m(1) + 
k(3)*m(10) + k(1)*m(11); %TCR-MHC-CD8 (LCK close) 
    dm(5) = -k(11)*m(5) - k(12)*m(5) + k(1)*m(12) + k(3)*m(9); 
    dm(6) = -k(2)*m(6) + k(9)*m(9) + k(8)*m(10) - k(13)*m(6) - 
k(14)*m(6); 
    dm(7) = -k(4)*m(7) + k(10)*m(12) - k(15)*m(7); 
    dm(8) = -k(4)*m(8) + k(10)*m(11) - k(15)*m(8); 
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    dm(9) = -k(9)*m(9) - k(2)*m(9) - k(3)*m(9) + k(12)*m(5) + 
k(14)*m(6); 
    dm(10) = -k(2)*m(10) - k(3)*m(10) - k(5)*m(10) - k(8)*m(10) + 
k(12)*m(4) + k(6)*m(2) + k(13)*m(6); 
    dm(11) = -k(1)*m(11) - k(4)*m(11) - k(5)*m(11) - k(10)*m(11) + 
k(11)*m(4) + k(6)*m(3) + k(15)*m(8);  







APPENDIX C. MATLAB CODE FOR SIMULATION OF CD8 
CATCH-BOND MECHANISM 
C.1 Code to run BFP assay for one ligand, several CD8:Lck fractions 
% Scan fraction of CD8:Lck conjugation, several runs of bfp assay and 
output lifetime results 
% Written by William Rittase 
 
% Requires inputs of number of runs, ligand, and the force/fraction of 




%% Q4R7 runs 
  
num_runs = 40; % number of cell pairs to simulation 
ligand = 'wQ4R7'; % which ligand to simulate 
force = [2,4,8,12,16,20,24,30]; % different force clamping levels (pN) 
num_forces = length(force); 
f = [0.01,0.02,0.04,0.08,0.1,0.15,0.2,0.4]; % fraction Lck conjugation 
to CD8 
  
for k = 1:length(f) 
  
    lifetimes = cell(num_runs,num_forces); % cell matrix to store 
lifetimes 
    start_times = cell(num_runs,num_forces); % cell matrix to store 
time at which lifetime was measured 
  
    for j = 1:num_forces 
  
        for i = 1:num_runs 
  
            [~,~,lifetime_store,lifetime_start_time] = 
tcr_lck_shp_switch_force_dependence_function_v4(force(j),ligand,f(k)); 
% simulate assay for one cell pair, one force 
  
            lifetimes{i,j} = lifetime_store; 
            start_times{i,j} = lifetime_start_time; 
  
            disp([num2str(j),',',num2str(i)]) 
  
        end 
  
    end 
  
    folder_path = 'input folder string'; 
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    file_path = ['workspace_wq4r7_',num2str(f(k)),'.mat']; 
  
    full_path = [folder_path,file_path]; 
  
    save(full_path) % save workspace for future analysis 
  
end 
C.2 Code to determine bond lifetimes for one cell and pair function 
function [m_store,t_store,lifetime_store,lifetime_start_time] = 
tcr_lck_shp_switch_force_dependence_function_v4(force,ligand,f) 
  
% Simulation of TCR pulling-stimulation induced CD8 conjugation through 
% activation of Lck and single phos of TCR. Shut down by GP (ppTCR 
% activated) 
tic 




num_touches = 200; % number of contacts in BFP assay 
contact_time = 0.1; % contact time (how long the cell and bead are in 
contact) 
waiting_time = 0.25; % waiting time (how long the cell and bead are 
separated after bond ends or there is no bond) 
dt = 0.001; % recording interval 
initial_af = 0.2; % adhesion frequency at the beginning of the assay 
pulling_rate = 200; % bond pulling rate up to clamping force in pN/s 
  
%% Densities 
mT = 8; % TCR density 
mC = 300; % CD8 density 
mC_L = f*mC; % CD8:Lck fraction 
mC_null = (1-f)*mC; % CD8 without Lck fraction 
mL = 20; % estimate from Germain PLoS Comp Bio 2005 (1um^2 area, 25nm 
depth) 
mGP = 80/3*mL; % as SHP from Germain 2005 
  
%% Peptide independent kinetics 
% Kinetic rates (force-free) 
kr_mc = 7.84; % CD8:MHC off rate 
kf_mc = 0.00004/6; % CD8:MHC on rate 
f_C = 21.9; % nominal force of CD8:MHC interaction under Bell model 
kr_tl = 0.1; % LCK:TCR estimated based on measurements by Chenqi Xu, 
high affinity, low off rate 
kf_tl = 1e-3; % LCK:TCR on rate 
  
k_pL_pulled = get_kpL_v4(force); % activation rate of Lck by pulled TCR 
k_phos_lck_by_ptcr = 0; % activation of Lck by partially activated TCR 
k_phos_tcr_by_lck = 0.03; % activation of TCR by active Lck 




k_gp_tcr = 0.01; % deactivation rate of TCR by GP 
k_gp_lck = k_gp_tcr; % deactivation rate of Lck by GP 
k_dephos = 0.1; % passive dephosphorylation 
  
k_enh_avidity = 100; % enhanced binding of MHC by TCR:CD8 dimers 
k_enhance_trapping = 10; % trapping enhancement of binding (doesn't 
really matter) 
k_enhance_rebinding = 1500/0.01^2; % Approximate fit to survival curve 
-  
% 0.01^2 is approximate grid area 
% 1500 could mean restrition in area to 0.5% or 1.8 degrees of 
% restriction, or grid area change to 0.005nm^2 (length of 0.0707nm) 
  
%% Peptide dependent kinetics  
% Import values 
[kr_tm,kf_tm,f_T,mM] = get_kinetics(ligand,initial_af,contact_time,1); 
  
%% Kinetic vectors 
k_all = [k_pL_pulled;... 
    k_phos_lck_by_ptcr;... 
    k_phos_gp_by_pptcr;... 
    k_phos_tcr_by_lck;... 
    k_gp_lck;... 
    k_gp_tcr;... 
    k_dephos;... 
    kf_tl;... 
    kr_tl;... 
    kf_tm;... 
    kr_tm;... 
    kf_mc;... 
    kr_mc;... 
    k_enh_avidity;... 
    k_enhance_trapping;... 
    k_enhance_rebinding]; 
     
k_no_pull = [0;k_all(2:end)]; 




%% Initial Species vector 
m_start = zeros(24,1); 
m_start(1) = mT; 
m_start(4) = mC_L; 
m_start(6) = mL; 
m_start(8) = mGP; 
m_start(10) = mM; 




options = odeset('RelTol',1e-5,'AbsTol',1e-7);%,'OutputFcn',@odewbar); 
  
t_contact = dt:dt:contact_time; 
t_wait = dt:dt:waiting_time; 
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m = m_start; 
  
bond_types = zeros(num_touches,1); 
  
t_store = []; 
m_store = []; 
accum_lifetime = []; 
  
bond = []; 
lifetime_store = zeros(num_touches,1); 
lifetime_start_time = zeros(num_touches,1); 
n = 0; 
  
for i = 1:num_touches 
  
    % Run contact time 
    k = k_no_pull; 
    [t_c,m_c] = ode45(@deq_switch,t_contact,m,options); 
  
    % remove all bonds (CD8:MHC,TCR:MHC) 
    m = m_c(end,:); 
    m(1) = m(1) + m(12) + m(17) + m(20); 
    m(2) = m(2) + m(13) + m(18) + m(21); 
    m(3) = m(3) + m(14) + m(19); 
    m(4) = m(4) + m(16) + m(20) + m(21); 
    m(5) = m(5) + m(22) + m(23) + m(24); 
    % m6-9 stay the same 
    m(10) = 0; 
    m(11) = m(11) + m(15) + m(17) + m(18) + m(19); 
    % m10-end become zero 
    for j = 12:24 
        m(j) = 0; 
    end 
     
    % Pulling time 
    r = rand; 
     
    prob_adhesion = 1-exp(-sum(m_c(end,12:24))); 
     
    if r < prob_adhesion % if bond 
         
        % Determine type of bond being pulled 
        bonds = m_c(end,12:24); 
        bonds_p = cumsum(bonds/sum(bonds)); 
        r = rand; 
        which_bond = sum(bonds_p<r)+1+11; 
        % determine if pulled bond survives and for how long it lasts 
        if which_bond >= 12 && which_bond <= 14 % if TCR-MHC bond 
  
            % determine if bond survives pulling 
            p_rup = 
prob_of_rupture_b4_clamp_v3(force,kr_tm,f_T,pulling_rate); 
            r = rand; 
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            if p_rup > r 
                % pull bond lifetime from distribution 
                pulled_T = 1; 
                bond = 'TCR:MHC'; 
                lifetime = get_lifetime(bond,ligand,force); 
                t_bond = 0:dt:lifetime; 
                bond_types(i) = 1; 
  
                n = n+1; 
                lifetime_store(n) = lifetime; 
                if ~isempty(t_store) % if first contact 
                    lifetime_start_time(n) = t_store(end)+contact_time; 
                end 
            else 
                pulled_T = 0; 
                t_bond = 0; 
            end 
             
        elseif which_bond == 15 || which_bond == 16 % if CD8-MHC bond 
             
            % determine if bond survives pulling 
            p_rup = 
prob_of_rupture_b4_clamp_v3(force,kr_mc,f_C,pulling_rate); 
            r = rand; 
             
            if p_rup > r 
                % pull bond lifetime from distribution 
                pulled_T = 0; 
                bond = 'MHC:CD8'; 
                lifetime = get_lifetime(bond,ligand,force); 
                t_bond = 0:dt:lifetime; 
                bond_types(i) = 2; 
  
                n = n+1; 
                lifetime_store(n) = lifetime; 
                if ~isempty(t_store) % if first contact 
                    lifetime_start_time(n) = t_store(end)+contact_time; 
                end 
            else 
                pulled_T = 0; 
                t_bond = 0; 
            end 
              
        elseif which_bond >= 17 && which_bond <=21 % if trimolecular, 
not pdd 
            % pull bond lifetime from distribution 
            pulled_T = 1; 
            bond = 'TCR:MHC:CD8'; 
            lifetime = get_lifetime(bond,ligand,force); 
            t_bond = 0:dt:lifetime; 
            bond_types(i) = 3; 
             
            n = n+1; 
            lifetime_store(n) = lifetime; 
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            if ~isempty(t_store) % if first contact 
                lifetime_start_time(n) = t_store(end)+contact_time; 
            end 
  
        else % pdd bond 
            % pull bond lifetime from distribution 
            pulled_T = 1; 
            bond = 'TCR:MHC:CD8L'; 
            lifetime = get_lifetime(bond,ligand,force); 
            t_bond = 0:dt:lifetime; 
            bond_types(i) = 4; 
             
            n = n+1; 
            lifetime_store(n) = lifetime; 
            if ~isempty(t_store) % if first contact 
                lifetime_start_time(n) = t_store(end)+contact_time; 
            end 
              
        end 
         
        % Simulate the system for the duration of the bond 
        % Immediately follow by simulating the waiting time in between 
        % contacts 
        if pulled_T == 1 
            k = k_pull; 
            if length(t_bond) >= 2 
                [t_b,m_b] = ode45(@deq_switch,t_bond,m,options); 
  
                k = k_no_pull; 
                [t_w,m_w] = 
ode45(@deq_switch,t_wait,m_b(end,:),options); 
            else 
                t_b = []; 
                m_b = []; 
                 
                k = k_no_pull; 
                [t_w,m_w] = ode45(@deq_switch,t_wait,m,options); 
            end 
        elseif pulled_T == 0 
            if length(t_bond) >= 2 
                k = k_no_pull; 
                [t_b,m_b] = ode45(@deq_switch,t_bond,m,options); 
  
                k = k_no_pull; 
                [t_w,m_w] = 
ode45(@deq_switch,t_wait,m_b(end,:),options); 
            else 
                t_b = []; 
                m_b = []; 
                 
                k = k_no_pull; 
                [t_w,m_w] = ode45(@deq_switch,t_wait,m,options); 
            end 
        else 
            disp('We have a problem in the pulling species') 
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        end 
    else 
        m_b = []; 
        t_b = []; 
        k = k_no_pull; 
         
        [t_w,m_w] = ode45(@deq_switch,t_wait,m,options); 
          
    end 
     
    % add contact time 
    [t_store,m_store,accum_lifetime] = 
add_stuff(0,t_store,m_store,accum_lifetime,t_c,m_c); 
    % add pulling time 
    [t_store,m_store,accum_lifetime] = 
add_stuff(1,t_store,m_store,accum_lifetime,t_b,m_b); 
    % add waiting time 
    [t_store,m_store,accum_lifetime] = 
add_stuff(0,t_store,m_store,accum_lifetime,t_w,m_w); 
     
    % Bring MHC back in and start over 
    m = m_w(end,:); 
    m(10) = mM; 





% Shorten matrices 
lifetime_store = lifetime_store(1:n); 




C.3 Code for get kinetics function 
function [kr_tm,kf_tm,f_T,mM] = 
get_kinetics(ligand,initial_pa,contact_time,get_mM) 
% Get kinetics for defined ligand 
% assume contact area = 1um^2 
% Inputs: 
% ligand = ligand string name 
% initial_pa = initial adhesion frequency for calculation of MHC 
density 
% contact_time = how long the cells are in contact during BFP assay 
% get_mM = 1 or 0, 1 if you want to calculate the MHC density 
  
% kf_tm = on rate for interaction 
% kr_tm = off rate for interaction 
% f_T = nominal force from Bell model fitting 





    kf_tm = 0.0000899378/6;  
    kr_tm = 4.22;          
    f_T = 30.2; 
     
elseif strcmp(ligand,'wQ4R7') 
  
    kf_tm = 0.000135225/6;  
    kr_tm = 3.45; 




    kf_tm = 0.0000592144/6;  
    kr_tm = 2.75;         




    kf_tm = 0.0000706784/6; % fit from other data 
    kr_tm = 4.15; % fit from other data 




    kf_tm = 0.0000457382/6;  
    kr_tm = 6.72;          




    kf_tm = 0.0000542196/6;           
    kr_tm = 3.63; 
    f_T = 11.9; 
     
else 
     




if get_mM == 1 
    mT = 8; 
    mC = 300; 
    kr_mc = 7.84; % CD8:MHC 
    kf_mc = 0.00004/6; % CD8:MHC 
    avg_num_bonds_T_over_MHC = (mT*kf_tm/kr_tm)*(1-exp(-
kr_tm*contact_time)); 
    avg_num_bonds_C_over_MHC = (mC*kf_mc/kr_mc)*(1-exp(-
kr_mc*contact_time)); 




    mM = -log(1-initial_pa)/avg_num_bonds_over_MHC; 
else 




C.4 Code to determine the probability of rupture before clamp function 
function p = prob_of_rupture_b4_clamp_v3(f,k_0,f_b,rf) 
% calculates the approximate probability of bond rupture before 
clamping 
% based on the clamping force (f), zero force off rate (k_0), scale 
% force(f_b), and ramping rate (rf) 
  
df = 0.01; 
  
if f > df 
  
    force = 0:df:f; 
  
    % probability that  
    pdf = k_0/rf*exp(force/f_b).*exp(-k_0*f_b/rf*(exp(force/f_b)-1)); % 
based on Eq 23 from Effects of cellular viscoelasticity in lifetime 
extraction of single receptor-ligand bonds 
     
    p = 1-trapz(force,pdf); 
     
else  
     
    p = 0; 




C.5 Code to select a lifetime function 
function [lifetime] = get_lifetime(bond,ligand,force) 
  
folder_path = 'input folder string’; 
file_path = strcat([folder_path,'/',ligand,'/',num2str(force)]); 
data = csvread(file_path); 
  
t = data(:,5); 
  
if strcmp(bond,'TCR:MHC') 
    m = data(:,1); 
     
elseif strcmp(bond,'MHC:CD8') 
    m = data(:,2); 
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elseif strcmp(bond,'TCR:MHC:CD8') 
    m = data(:,3); 
     
elseif strcmp(bond,'TCR:MHC:CD8L') 
    m = data(:,4); 




p = rand; % probability 
index_gt = sum(m>p)+1; 
index_lt = index_gt-1; 
  
if index_gt > length(m) 
    lifetime = t(end); 
else 
    lifetime = (p-m(index_lt))/(m(index_gt)-m(index_lt)) * 




C.6 Code to compile data function 
function [t_store_out,m_store_out,accum_bond_lifetime_out] = 
add_stuff(is_bond,t_store_in,m_store_in,accum_bond_lifetime_in,t,m) 
% Append matrices and adjust things 
  
if is_bond == 0 % if there is no bond 
    if isempty(accum_bond_lifetime_in) % if first run 
        accum_to_add = zeros(size(t)); 
        t_to_add = t; 
    else 
        accum_to_add = repmat(accum_bond_lifetime_in(end),size(t)); 
        t_to_add = t + t_store_in(end); 
    end    
     
    accum_bond_lifetime_out = [accum_bond_lifetime_in;accum_to_add]; 
    t_store_out = [t_store_in;t_to_add]; 
    m_store_out = [m_store_in;m]; 
else 
     
    t_to_add = t + t_store_in(end); 
    accum_to_add = accum_bond_lifetime_in(end) + t; 
     
    accum_bond_lifetime_out = [accum_bond_lifetime_in;accum_to_add]; 
    t_store_out = [t_store_in;t_to_add]; 
    m_store_out = [m_store_in;m]; 
end 
      
end 
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C.7 Code to plot lifetimes and extract data from workspace script 
% Plot lifetime curves or distributions for a specific ligand across 
% several CD8:Lck fractions 
% Input the workspace file 
% Requires changing folder_path/workspace_name to reflect several runs 





f = [0.01,0.02,0.04,0.08,0.1,0.15,0.2,0.4]; 
n = length(f); 
  
folder_path = 'input folder string'; 
workspace_name = ['workspace_wq4h7_',num2str(f(1)),'.mat']; 
  




lifetimes_in_force_bin = cell(num_forces,n); % lifetimes in each bin 
mean_lifetime = zeros(num_forces,n); % average lifetime in bin 
stderr_lifetime = zeros(num_forces,n); % standard error of lifetime in 
bin 
n_lifetime = zeros(num_forces,n); % number of lifetimes in each bin 
stdev_lifetime = zeros(num_forces,n); % standard deviation of lifetimes 
in each bin 
  
for index = 1:n 
  
    folder_path = '/Users/williamrittase/Dropbox (GaTech)/Simulations 
in development/Switch/Lck-Shp change bond lifetime/workspaces/v5 
scan/h7/'; 
    workspace_name = ['workspace_wq4h7_',num2str(f(index)),'.mat']; 
  
    full_path = [folder_path,workspace_name]; 
  
    load(full_path) 
  
    % important variables: lifetimes, start_times, force, 
    % num_forces, num_runs 
  
    for i = 1:num_forces 
  
        lifetimes_all = []; 
  
        for j = 1:num_runs 
  




            lifetimes_all = [lifetimes_all;lifetimes_now]; 
  
        end 
  
        mean_lifetime(i,index) = mean(lifetimes_all); 
        stderr_lifetime(i,index) = 
std(lifetimes_all)/sqrt(length(lifetimes_all)); 
        lifetimes_in_force_bin{i,index} = lifetimes_all; 
        n_lifetime(i,index) = length(lifetimes_all); 
        stdev_lifetime(i,index) = std(lifetimes_all); 
  
    end 
  
    % Plot lifetimes 
    scatter(force,mean_lifetime(:,index)) 
    hold on 
    
errorbar(force,mean_lifetime(:,index),stderr_lifetime(:,index),'LineSty
le','none') 
    xlabel('Force (pN)') 
    ylabel('Average Lifetime (sec)') 
  
    a = gcf; 
    a.Color = [1,1,1]; 
    a.Children.Children(1).LineWidth = 2; % set error bar size 
    a.Children.Children(2).LineWidth = 2; % set dot size 
    a.Children.Children(2).SizeData = 80; 
    a.Children.Children(2).CData = [0.8500 0.3250 0.0980]; 
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